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 ABSTRACT 
Background and Significance: Asthma remains one of the most prevalent chronic diseases 
affecting the pediatric population.  The burden of disease asthma poses to children in the United 
States serves as evidence of its far-reaching life-altering potential: the CDC estimates that, in 
2013, 6,109,000, or 8.3% of all US children under age 18, were diagnosed with asthma.  
However, it is clear from the data that wide gaps exist in current management practices among 
pediatricians, despite the fact that best practice guidelines are in place.  Quality improvement 
processes stand to change the face of this variation, but not before we understand which parts of 
the QI process are effective, and which are unhelpful. 
Purpose: The purpose of this systematic review is to conduct a methodological review of the 
literature to better understand the following questions: What types of quality improvement 
initiatives are clinicians who provide care for the pediatric asthma population currently 
undertaking?  What variables determine which quality improvement initiatives are successfully 
implemented, and what effect does this implementation have on health outcomes? 
Methods: Data were abstracted and extracted using a critical appraisal table by an individual 
reviewer.  No meta-analyses were performed.  Summary measures included p-values and odds 
ratios with confidence intervals.  
Results: Thirteen articles were retrieved from PubMed.  Three met the pre-defined inclusion and 
exclusion criteria and were included in this systematic review.  Overall, quality improvement 
initiatives that aim to address current management practices of pediatric patients with asthma 
tend to have large, positive influences on outcomes.  The challenges providers face oftentimes 
are in the form of deciding which variables the initiative should address, in generating buy-in 
from key stakeholders, and, closely related to generating buy-in, finding ways to incorporate 
concerns identified by key stakeholders in the developmental stages of the quality improvement 
process.  A key variable determining the success of implementation is the degree to which 
leaders of the quality improvement initiative are able to gain key stakeholder interest, and, by the 
same token, the level to which the initiative is able to address parts of the care process that key 
stakeholders identify as important.   
Discussion: The evidence from this systematic review both highlights that the implementation of 
quality improvement initiatives can be done successfully, and that, when done successfully, can 
have a considerably large effect on the health outcomes of members of the pediatric asthmatic 
population.  What is more, it demonstrates key variables that help define or predict whether the 
initiative may be a success or failure.  Paying attention to the opinions and perspectives of staff 
members appears to be an important characteristic of an implementation process that will likely 
be successful, as is implementing components of the quality improvement initiative in phases.  
Of all that the evidence suggests, perhaps the most important is the breadth of effect quality 
improvement initiatives can have.  We have more work to do, however. 
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 Limitations: The main limitation, however, is the fact that only three eligible studies were 
identified.   
  A. Webb 
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I. INTRODUCTION| 
Background and Significance 
Asthma remains one of the most prevalent chronic diseases affecting the pediatric 
population.  For years, health professionals have noted the comparability of asthma to obesity in 
the potential of each of them to harm children’s quality of life.  The burden of disease asthma 
poses to children in the United States serves as evidence of its far-reaching life-altering potential: 
the CDC estimates that, in 2013, 6,109,000, or 8.3% of all US children under age 18, were 
diagnosed with asthma.
i
  What is more, researchers predict that, in the future, this number will 
only continue to rise.  As if asthma’s burden of disease is not alarming enough, the morbidity 
and mortality of this disease in the pediatric population underscore its true consequences.  Each 
year, numerous children with asthma visit emergency departments, are hospitalized in intensive 
care units, and are placed on mechanical ventilation.
ii
  Some of these children will recover, but 
the harsh reality is that asthma will make others so sick they will die.  Between 2010 and 2011, 
asthma caused nearly 3 million pediatric deaths.  Furthermore, in 2008, the disease was 
responsible for 10.4 million missed days of school, 1.8 million emergency department visits, and 
1.3 million outpatient visits, with the latter two figures measured during 2011.
iii
   
The National Heart, Lung, and Blood Institute’s National Asthma Education and 
Prevention Program (NAEPP) guidelines are widely accepted by pediatricians as standards of 
care for asthma management.  Despite this, research has demonstrated that physicians implement 
these guidelines into clinical practice at differing rates.
iv
  Why is this so?  Given the very well-
understood importance of providing appropriate and high quality care to the pediatric patient 
with asthma, why do the data suggest these gaps in physicians’ ability to do so?  One way to 
answer this multi-layered question is by examining which health policies have helped physicians 
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improve care to children with asthma.  Part and parcel of this effort is to understand the barriers 
pediatricians face to implementing standardized models of care.  
 Managed care and its implications for quality improvement are central to an 
understanding of current pediatric asthma management practices.  Managed care organizations 
(MCOs) adopt a health care delivery model in which providers and insurance companies 
negotiate prices for medical services that are then offered to insured patients, often at discounted 
rates.  At their inception, the goals of MCOs, though not limited to the following, were three-
fold: to yield better access to health care by lowering costs; to lower the overall costs of health 
care by having primary care physicians serve as “gatekeepers” of care; and, to reduce the 
carefree utilization of health care that continually raises its cost.  Implementation of the latter has 
occurred through the requirement that primary care physicians must approve a patient’s request 
to obtain care from specialty providers.  Millions of insured Americans receive care from health 
care facilities operating under the MCO model.  Further, most insured patients are covered by a 
type of managed care insurance plan, including young asthmatic children, and at some of the 
highest rates for any patient population suffering from chronic disease.
v
  
 A chief consequence of the adoption of the MCO model was the imposition of quality 
metrics designed to evaluate the quality of health care delivery and improve standards for disease 
management.  A logical goal, the Kaiser Family Foundation reports that in 2015, MCOs in more 
than half of the fifty states report data on quality.
vi
  Importantly, however, a spectrum of 
organizations comprises these MCOs, and they exist on a continuum of settings that operate 
under the principles of managed care.  Consequently, prominent variations exist in the 
implementation of quality improvement methods by numerous health care organizations.  
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Further, these variations have important implications for the clinical management of children 
who are treated for asthma in the primary care setting.   
A study by Cabana, Dombkowski, Yoon, and Clark highlights differences in quality 
improvement initiatives across MCOs as variables important in shaping the current state of 
asthma management in pediatric patients.  The authors conducted a survey within nineteen 
Medicaid managed care organizations in Michigan to evaluate their hypothesis that variations in 
quality improvement initiatives exist, and that these variations can help to explain the status of 
asthma care.  Despite the inclusion of quality improvement programs across the majority of 
MCOs studied, “the breadth and depth of such programs vary widely.”vii  What is more, the 
authors found that the type of quality improvement intervention used most commonly by MCOs 
was the type noted in several research studies to be ineffective: continued physician education.  
The most commonly used patient-focused quality improvement intervention was patient 
education via mailings.  But, again, this method has been shown not to be effective in improving 
asthma-specific health outcomes. 
 Variations in quality improvement methods implemented by MCOs highlight the 
challenges pediatricians face in developing effective asthma management paradigms and putting 
them into clinical practice.  The patient-centered medical home serves as a model that effectively 
addresses the challenges of managing pediatric asthma care.  Still, while several health care 
organizations have successfully implemented this type of model, there are differences in the rates 
at which others have been able to do so.  In a cross-sectional serial analysis performed on a 
sample of children hospitalized for acute asthma between the years 2000 through 2009, 
Hasegawa et al. obtained data on outcome measures that included the following: asthma 
hospitalization incidence, in-hospital mortality, mechanical ventilation use, and hospital 
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charges.
viii
  During the study period, the incidence rates of asthma hospitalization fell from 21.1 
to 18.4 per 100, 000 person years in 2000 to 2009, respectively.
ix
  However, mechanical 
ventilation use in the sample population increased, as did hospital charges.  Additionally, Patricia 
Li et al. conducted a study analyzing the relationship between emergency department visits for 
acute asthma exacerbation and rates of follow-up care.  Li found that most children did not 
access care following an emergency department visit for acute asthma care.
x
  The study was 
conducted in Ontario, Canada, which does not limit its applicability; the fact that it was 
conducted under conditions of a universal health insurance system further raises questions about 
how MCOs affect the management of insured children who receive care at these organizations.   
Differences in implementation point to barriers in putting what studies demonstrate 
works for pediatric asthma care into clinical practice.  Viswanathan, Mansfield, Smith, and 
Woodell et al. aimed to further define these barriers in their cross-site evaluation of the 
implementation of a comprehensive pediatric asthma quality improvement initiative.  Pediatric 
primary care clinics in New York City, San Juan, Chicago, Los Angeles and Philadelphia 
comprised the five sites included in the Merck Childhood Asthma Network (MCAN) initiative.  
Quality improvement asthma plans had already been established at the five sites.  Each site “was 
unique in its combination of interventions, but all sites served common goals of integration of 
care, incorporation of evidence-based programs, and improvement in knowledge, self-
management, health, and quality of life.”xi  The Network evaluated the challenges associated 
with translating evidence-based interventions into clinical practice changes measured across 
several variables of implementation.  These variables included improvement in outcomes such as 
asthma symptoms, access to high-quality care, appropriate use of the health care system, and 
improved quality of life for children who have asthma.  The evaluation employed the RE—AIM 
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framework— reach, effectiveness, adoption, implementation, and maintenance— to assess 
barriers of implementation.  The authors’ evaluation found that a key problem in implementation 
is, in fact, the challenge of effectively evaluating the success of interventions in a way that helps 
support or contest in a way that meaningfully progresses the implementation process.     
Other barriers that impede implementation of effective management practices include 
patients’ and providers’ perceptions of asthma care, characteristics of the practice’s patients, 
characteristics of the providers, characteristics of the practice, and characteristics of the disease 
management program, itself.  A study by Mowrer, Tapp, Ludden, and Kuhn et al. explored how 
differences in patients’ and providers’ perceptions of asthma and asthma care influenced 
successful treatment of the disease.  The authors used qualitative methods to address the 
question.  Specifically, parents, children, physicians, and other clinical staff from 15 diverse 
practice settings across the Charlotte, NC area participated in focus groups every 6 months for 3 
years.  Participating practices included specialties in pediatrics, family medicine, and internal 
medicine.  Importantly, participating practices were those undergoing implementation of novel 
asthma management practices during the study period.  During each focus group meeting, 
questions aimed at understanding the perceptions of both groups about goal setting, asthma 
action plans, and preventive strategies for asthma exacerbations were asked.  Themes across 
three broad categories emerged: (1) cost/economic barriers,(2) self-governance/adherence, and 
(3) education.   
In particular, barriers to effective care included high cost of medications to patients and 
the physicians’ perceived lack of knowledge of such cost.  Further, discrepancies in the 
physicians’ perceived value and importance of the asthma action plan and patients’ perceptions 
of the importance played an important role in implementation processes in the participating 
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clinics.  The need for better education about asthma was noted on both sides, with patients 
asserting physicians’ lack of knowledge about insurance formularies as a key barrier, and 
physicians noting an overall lack of the public’s awareness about the importance of preventing 
asthma exacerbations.
xii
  A similarly designed study conducted by Brazil, Cloutier, Tennen, and 
Bailitt et al. examined the characteristics that influenced implementation of the Easy Breathing 
Disease Management Program across pediatric primary care clinics in Connecticut.  The authors 
noted that barriers related to physicians’ lack of confidence, practice variables that affect 
initiative assimilation, patient characteristics, and characteristics of the disease management 
program were variables important in understanding hindrances of the implementation process.  
Specifically, the authors found that physicians commonly lacked confidence in their ability to 
implement changes in the already established practices of managing pediatric asthma patients.  
Lack of belief in the ability to affect existing asthma health outcomes was another common 
theme.  Adequate staffing and time to implement the disease management program were 
important issues related to practice characteristics that affected implementation.  Providers 
discussed fears that certain patient demographics, particularly a low socioeconomic status, may 
prevent adherence to the recommendations.  Further, some expressed resentment of parts of the 
disease management program they felt standardized patient care (e.g., at the expense of 
individualized care).
xiii
   
 Current management practices of asthma in the pediatric population are important to 
consider, especially in light of the burden of disease on one of the most vulnerable 
populations,young people.  Nevertheless, there are gaps in care, as evidenced by ongoing large 
numbers of hospitalizations and emergency department visits for asthma care.  Studies have 
shown that the patient-centered medical home model provides a framework for effectively 
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managing pediatric patients who need asthma care.  What is more, data indicate several 
organizations that have successfully implemented this model have reduced poor health care 
utilization, combated rising health care cost, and improved the quality of care these patients 
receive.  The overarching issue, however, appears to be the methods for quality improvement 
that are employed, and how effective physicians are at implementing them.  Barriers exist to 
successfully implementing the patient-centered medical home model, including practice 
characteristics, physician and patient attitudes and perceptions of what is important in asthma 
care, and the challenges some practices face in measuring the effectiveness of new management 
strategies that are employed.   What we do know, however, is that comprehensive care outweighs 
individualized care in terms of benefits and quality.
xiv
  Furthermore, pediatric collaborative 
networks for quality improvement may be a good place to start.
xv
 
 Despite the fact that largely logical thinking and basic ideas of creating change comprise 
it, the quality improvement process is complex.  The principal reason for this complexity is that 
quality improvement includes several small components of change, as well as ideas and concepts 
that must be executed in a highly systematic way.  Oftentimes, the degree to which members of a 
quality improvement team understand these components, thought processes, and ideas 
predictably determines the success of the initiative, measured by most as the initiative’s ability to 
successfully implement change, or clinical management practices, that the project has shown to 
be effective systemically— that is, across an entire organization or practice, in a standardized, 
reproducible way.  Equally important, however, are the perceptions members of the quality 
improvement team hold regarding the changes being made.  In other words, part of quality 
improvement’s systematic nature requires gathering information from key stakeholders about 
why, from their perspectives, the goal of the initiative is important, what they identify as the 
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variables contributing to the existing problem, what they perceive as their role in hindering or 
facilitating changes to the existing system, and how they perceive the changes being put forth 
and implemented throughout the initiative’s course.xvi 
 Aside from their consideration from the standpoint of carrying out a necessary part of the 
quality improvement process, understanding providers’ perceptions of the changes taking place 
can provide valuable insight that allows the unearthing of the key variables that impede the 
implementation of standardized clinical practices the quality improvement process has 
demonstrated to be most effective.  Though this consideration likely has value for all quality 
improvement initiatives, given the overwhelming morbidity, mortality, cost, and lack of 
standardized care provided for pediatric patients suffering from asthma, the application of this 
consideration to this debilitating chronic disease can be regarded as having an extremely high 
value.  What are the perceptions of providers who take part in quality improvement initiatives 
related to pediatric asthma?  What do providers identify as major problems with their ability to 
effectively provide care to pediatric asthma patients in a standardized way, using best-evidenced 
guidelines to improve the clinical management of these children?  How well do providers 
understand the quality improvement process?  Do providers believe in the process? 
 For all their importance, data on each of these questions, especially as they apply 
specifically to the field of pediatric asthma, are significantly limited.  However, that is not to say 
that the questions must go unexamined, or that they must remain unanswered; existing data do 
allow for other important questions to serve as proxies.  Though there may be limitations to 
using proxies to examine the questions at hand, these limitations can be considered small in 
comparison to not considering the questions at all.  One way of examining the questions includes 
investigating what providers have identified as key environmental contextual variables that can 
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influence the success of a quality improvement initiative.  That is, what does one’s work 
environment have to do with the ability of its employees to follow the improvement steps that an 
initiative requires?  Another way to examine the question includes the consideration of the key 
components of a quality improvement initiative providers have identified as required for the 
subsequent successful, standardized implementation of effective clinical practices.  Finally, an 
alternative approach includes exploring data on different techniques that have been employed in 
the clinical setting to enhance physicians’ performance improvement, another important aspect 
of the quality improvement process.  The goal of this paper is therefore to provide a brief 
analysis, exploring answers to these questions using research from three articles examining these 
issues.   
 The first approach considers work environment contextual variables that may influence 
the ease with which standardized clinical practices that improve patient care can be implemented, 
or whether, in certain instances, contextual variables make it impossible to do so.  At the outset, 
it must be said that technological advancements, research demonstrating best-evidenced clinical 
practices, and other improvements meant to improve patient satisfaction and quality of care are 
often considered to have an unintended stumbling-block effect by which the clinical staff 
responsible for implementing and utilizing the improvements suffer from significant 
dissatisfaction with work environment.  This is due, in large part, to the fact that guidelines on 
how to most effectively implement these changes seldom exist, thereby calling on clinical staff 
to devise ways to incorporate sometimes large changes into their existing systems of care.  
Oftentimes, burnout is the result.
xvii
  These larger, contextual variables notwithstanding, a study 
by Wallin, Ewald, and Wikblad, et al. aims to examine the contextual variables operating on 
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smaller scales within the clinical environment that often are responsible for negotiating the large 
scale success of implementation of evidence-based practices. 
The authors of this article focus on the effect of contextual variables on the 
implementation of evidenced-based practices at the level of nursing care in neonatal intensive 
care units.  Specifically, the authors designed a multicenter study consisting of four sites to 
evaluate facilitation support for guideline implementation.  Measures included contextual 
variables, the clinical staff’s perceptions of change, and patient outcomes; the latter were 
measured twice during the study period.  The authors aimed to determine changes in staff 
perceptions over time, in order to identify the contextual variables most likely to predict the 
potential for work environment implementation of improvements.  To answer their question, the 
authors administered the Quality Work Competence Questionnaire to study participants.  The 
authors identified several important contextual variables that can affect best-evidenced clinical 
practice implementation.  A critical variable included skills development and performance 
feedback.  In particular, utilization of skills, development of skills, personal development, and 
management support for development were all identified as variables important for the ability of 
a clinical environment to adopt change.  Of importance, organizational learning, or learning that 
is structured into the clinical environment as opposed to individual learning that takes place in 
one’s own time, was identified as the specific type of learning most valued and most effective for 
implementing change.  Participatory management, or shared responsibility between individuals 
considered to be at different levels of training, was also identified as an important variable.
xviii
 
In the literature, what providers deem as the essential components of a quality 
improvement initiative that aid in its success is often measured as provider satisfaction with 
changes that occur as a result of the initiative.  Apart from its importance as a marker of the 
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likelihood that providers will continue employment at a given work environment, provider 
satisfaction has been recognized as an important variable that plays a role in the ability for 
quality improvement changes to be implemented in various clinical settings.  Organization 
culture, or the characteristics of a given clinical environment, has also been viewed as a major 
variable that can determine the effectiveness or ability of major quality improvement changes to 
be incorporated into existing workflow, or clinical practices.  Taken together, understanding the 
relationship between provider satisfaction and organization culture can be viewed as providing 
an invaluable picture of what providers think is important to adapting quality improvement 
changes in a clinical organization.   
A study conducted by Scammon, Tabler, and Brunisholz et al. sought to examine this 
relationship.  In it, the authors explore the relationship between organization culture and provider 
satisfaction in the context of implementation of a major quality improvement strategy: practice 
transformation into a patient-centered medical home.  The study has particular relevance to 
quality improvement and the management of patients with pediatric asthma, as the patient-
centered medical home has been identified by many as a major strategy to improve outcomes in 
this population.  The authors conducted a cross-sectional study in which surveys were 
administered to providers in ten primary care clinics that were implementing the patient-centered 
medical home model.  Surveys administered included the Organizational Culture Assessment 
Instrument and the American Medical Group Association provider satisfaction survey.  Providers 
reported satisfaction with the quality of care they felt they were able to provide patients, as well 
as interactions with patients.  Within the patient-centered medical home model, providers were 
least satisfied with time spent working, paperwork completion, and compensation.
xix
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Tying finances, or cost, directly to physician performance can be challenging mostly 
because of the detrimental implications doing such a thing may have for the clinical 
environment, morale, and behavior of staff, the importance of which has previously been 
discussed.  Nevertheless, the link between cost and quality of care is an essential component of 
performance improvement, an aspect of quality improvement initiatives that, for reasons likely 
related to the discomfort it evokes among providers and administrators, alike, is often not readily 
discussed.  The field advocating for the use of financial data to tie together care and performance 
improvement is referred to as clinical analytics.  According to Ross Hammarstedt and Deborah 
Bulger, by directly linking care and cost, clinical analytics affords a transparency that allows 
improvements in quality in several different ways.  For example, clinical analytics allows clinical 
performance to be measured using clinical data; that is, performance can be measured using data 
based on metrics of patient care rather than that based on patient billing.  Another important 
advantage of clinical analytics, according to the authors, is that it supports a metric-driven 
culture that enables clinical staff participating in quality improvement initiatives to understand 
the meaning of quality for their organization, and to understand their roles for influencing 
improvements in care.
xx
 
Objectives 
Given what is already known, the principal aim of this systematic review is to formally 
undertake several questions about quality improvement and the implementation process, 
specifically as each applies to the unique set of challenges caring for a pediatric patient with 
asthma entails, as previously described.  Such a large goal has at its center the hope of providing 
an overview of the most current literature and data that answers, most broadly, the types of 
quality improvement initiatives that providers who care for pediatric asthmatics have created.  
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This includes a deep exploration of the initiatives’ components, organization of the project, and 
rationale for why the initiatives included the components that each did.  Additionally, this 
systematic review seeks to better understand the implementation process.  For example, an aim 
of the review is to provide an answer to the questions data that demonstrate variations in 
implementation rates beg; namely, what are the steps providers take to transition from concept to 
practice, and what variables determine if and when the goals set forth by the initiatives are met? 
With feasibility principles in mind, the questions most specific to what this systematic 
review aims to address have been constructed using the PICOTS format.  Populations included 
the following: primarily, children between the ages of 2 and 18 who were diagnosed with 
asthma; sub-populations of interest to this research question included minorities and those 
characterized as meeting the criteria for low socioeconomic status.  Rationale for consideration 
of these sub-groups as the specific populations on which this systematic review focuses is the 
fact that members of the aforementioned historically and consistently demonstrate higher rates of 
asthma-related health care utilization compared to white children and others who are not 
members of these groups.
xxi
  Interventions included those denoted as being a part of 
implementation of a quality improvement initiative.  These included, but were not limited to, 
implementation of asthma care pathways, analysis of current provider practices, and the creation 
of communication tools.  Comparators were outcomes data collected at pre- and post-
implementation time points.  Outcomes of interest included the following, in no order of 
relevance or importance: time to reliever medication administration; asthma score assessment; 
emergency room visits; hospitalizations; school performance; and number of school absences.  
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II. METHODS| 
Eligibility Criteria 
Much like the quality improvement process, the formulation of the questions this 
systematic review seeks to address occurred via an iterative process.  Most important to the 
purpose of this systematic review was to come away from the literature with a better 
understanding of the types of quality improvement initiatives that have been or are currently 
being employed by providers taking care of pediatric patients with asthma, the correlative 
question being why providers choose to implement a quality improvement initiative in the first 
place.  Are they short-staffed and trying to deliver better care quality in a limited-resource 
setting?  Are they working at tertiary medical centers where the main driver has been determined 
to be that asthmatic patients return to the emergency department at a rate that the academic 
center, from a financial standpoint, has deemed is too high?  Are they working in community 
emergency departments and not meeting the recommended national guidelines for medical work-
up and management of pediatric patients with asthma? 
The last question is of particular interest to this systematic review, and is tied closely with 
the other main consideration this review addresses: once initiated, how are quality improvement 
projects aiming to change the face of current clinical care practices for this important health 
population implemented?  More specifically, what variables determine the success of 
implementation?  As previously described, there are data to suggest that there are wide gaps and 
variations in the ability of pediatricians and other health care providers who engage with 
pediatric asthmatics to follow the set of standardized guidelines set forth by national 
organizations as best evidence clinical practice.  Have the providers who are offering care in 
accordance with these guidelines developed a system of implementation that providers who are 
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struggling to meet these standards have not?  Looked at on a more practical, smaller scale, what 
about a quality improvement initiative predicts whether its concepts and principles can 
effectively and efficiently be adopted? 
In PICOTs terms, the question this systematic review seeks to answer is whether children 
between 2 and 18 who have been diagnosed with asthma have better or worse health outcomes 
after the implementation of a quality improvement initiative at the location where they receive 
care compared to the care they received before the implementation took place.  The supplemental 
question includes details about the implementation process, and what variables affected whether 
quality improvement initiative implementation was a success or failure.  The following were the 
eligibility criteria used to select articles for review.  A more detailed list of inclusion and 
exclusion criteria, in addition to rationale (when appropriate), can be found in Figure 1.  Briefly, 
the eligibility criteria used to select a study for review included the following: (1) the study 
population included pediatric patients between the ages of 2 and 18 who had been diagnosed 
with asthma; (2) the study design included the use of quality improvement methods; and (3) the 
study design included implementation of a quality improvement initiative.  In addition, studies 
that were not published within at least the last 10 years were excluded. 
PICOTS  
Inclusion Criteria  
   
Exclusion Criteria 
Population(s)  
Children age 2-18 diagnosed 
with asthma. 
 
Subpopulations of interest: 
minorities, low 
Patients younger than 2 and older than 18. 
 
Patients without asthma. 
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socioeconomic status. 
Interventions  
Quality improvement 
initiatives, including but not 
limited to implementation of 
standardized asthma 
pathways, development of 
communication quality 
improvement tools, small 
scale changes to clinical 
practices already in place, 
meetings with key 
stakeholders to identify key 
drivers and determine 
variables on which to base 
change. 
Study design does not assess the 
effectiveness and characteristics of the 
implementation of a quality improvement 
process.   
 
Study does not include a quality 
improvement initiative as a main question or 
focus. 
  
Comparators  
Pre-implementation versus 
post-implementation. 
 
--------------------------------------------------- 
Outcomes  
Primary outcomes: health 
care utilization, mortality. 
Secondary outcomes: 
improvement of asthma care 
management, emergency 
department visits, school 
absences, school 
performance. 
 
 
------------------------------------------------------ 
Timing  
Studies published less than 
10 years ago. 
Studies published more than 10 years ago. 
Settings  
Any health care delivery 
setting: in-hospital, 
outpatient, community 
hospital, tertiary (academic) 
medical center, other health 
 
----------------------------------------------------- 
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Figure 1.  PICOTS Table illustrating the inclusion and exclusion criteria used for study selection.  
Information Sources & Literature Search 
 Information sources included for review were solely those in the form of 
published articles.  No clinical trials related to this systematic review’s topic were identified.  In 
the event that they had been, literature would likely have been the only information source used 
given the nature of the review’s question.  The literature search was conducted on PubMed and 
included the following search terms: “Pediatric AND asthma AND quality improvement AND 
implementation AND outcomes.”  This search was conducted on March 15, 2018.  This search 
yielded 13 articles (Appendix, “PubMed Literature Search”).  The articles were then reviewed 
for inclusion or exclusion in this systematic review based on criteria detailed in the section 
above.  The study selection process continued with review of article abstracts.  Articles that were 
published prior to the year 2008 were excluded.  The rationale for this is based on the 
presumption that literature published more than 10 years before the search date would not be 
current enough for the results to hold relevant.  This excluded 4 studies.  Article abstracts were 
then reviewed to determine whether the study design included the populations of interest.  No 
studies were eliminated using this selection criterion.  The remaining 9 article abstracts were 
reviewed to determine if the study included (1) quality improvement methods, and (2) clear 
indication that the study design included implementation of a quality improvement initiative, in 
professional offices, 
patient’s residence. 
Study Designs  
 Any study design 
employing quality 
improvement methodologies. 
  
Any study design not employing quality 
improvement methodologies. 
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addition to analysis of outcomes at pre- and post-implementation time points.  This excluded 5 
additional studies.  The remaining 4 were included for review.          
Study Selection 
 The study selection process is summarized above.  Here, a visual of the study selection 
process is provided in the form of an article flow diagram (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 articles remained after review of article titles for 
duplication and screening of articles for relevance.  
Studies were deemed relevant if the article title and/or 
abstract indicated that the patient population of interest 
to the study included pediatrics and/or the topic of 
interest to the study included asthma. 
Article #6 excluded for 
similarity to Article #5.  Article 
#5 was included because its 
publication date is more recent. 
13 full text articles assessed for eligibility. 
9 full text articles excluded from review: Article #10-
#13 excluded for publication date before 2008.  
Article #9 was not specific to the population of 
interest (examined pediatrics patients, but not those 
who were asthmatic, explicitly.)  Article #2, #4, #7 
and #8 were excluded because respective study 
designs did not include the implementation of a 
quality improvement initiative.   
 
3 full text articles included in qualitative synthesis. 
Inclu
ded 
Eligi
bility 
Scree
ning 
Identif
ication 
Figure 2.  Article Flow Diagram. 
13 articles identified by searching 
PubMed. 
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Data Collection Process 
Data were abstracted from each article by an individual reviewer (this writer).  A second 
reviewer was not involved in the research for this systematic review, including the data 
abstraction and extraction processes.  Following a second thorough review of article abstracts to 
confirm appropriateness of the inclusion of each article based on the pre-set eligibility criteria, 
methods for the data abstraction process were devised.  The main goal of this systematic 
review’s data abstraction process was to develop a concrete, systematic way to derive 
information pertinent to answering this review’s main questions without introducing any bias.  
The following subset of information was deemed important to obtain from each article, in 
sequential order: article citation; study question and research design; the study population; risk of 
selection, measurement, and publication bias; overall judgement of internal and external validity; 
and results.  These were the characteristics of each study judged to be essential.  The data 
extraction process consisted of reading each article twice; once for the purpose of obtaining the 
study characteristics that were pre-defined as essential, and a second time to ensure that other 
components of each article that were not especially essential but were still relevant to the overall 
critical appraisal process were collected.  Data items collected were recorded in critical appraisal 
tables; each article has its own completed critical appraisal table.  Use of the table ensured that 
no data items were missed, that each article was reviewed using a clear framework, that the data 
were abstracted from each article in the same sequential order every time, and that the quality of 
each article was thoroughly and critically assessed.  
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Risk of Bias in Individual Studies & Summary Measures 
The risk of bias in individual studies was evaluated primarily by using the same critical 
appraisal table that included the data items for the abstraction process as a guide.  For the 
purposes of this systematic review, three main types of bias were considered: selection bias, 
measurement bias, and confounding. The presence or absence of each type of bias, and, if 
applicable, the degree to which each type of bias was present were considered in the 
determination of the overall internal validity of each study.  The overall internal validity, in 
addition to the external validity, was the main determinant of each study’s judged quality.  A 
sample critical appraisal table can be found below (Figure 3), and the completed critical 
appraisal tables for each article can be found in the appendix of this systematic review 
(Appendix, Table 1).  Summary measures included p values and odds ratios with confidence 
intervals. 
1. Citation (JAMA style) 
 
 
2. Study question and 
research design  
 
 
3. Source Population 
 
 
4. Study population 
(descriptive: 
demographics, eligibility 
criteria) and how chosen 
(volunteers, recruitment, 
tertiary care clinics, 
population-based, etc) 
 
 
5. Initial comparability of 
groups (ie, randomization 
or group composition; 
concealment of allocation) 
 
 
6. Drop outs (no endpoint 
data), adherence, cross-
overs (other terms: 
attrition; loss to follow-
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up) 
 
7. Potential for selection 
bias (grade + to +++, and 
explain) 
 
 
8. Measurement (of 
exposure/intervention; 
outcomes; potential 
confounders): reliability 
and validity of 
measurement 
instruments; how 
measurements were 
performed; include 
blinding if needed ) 
 
 
9. Potential for 
measurement bias (grade 
+ to +++, explain ) 
 
 
10. Potential confounders 
(name what they are and 
how each was controlled: 
ie, by randomization, 
restriction, statistical 
adjustment, stratification, 
etc) 
 
11. Potential for 
confounding (grade + to 
+++, explain)  
 
 
12. Analysis (intention to 
treat if applicable, other 
adjustment) 
 
 
13. Results: magnitude 
and direction (point 
estimate); random 
error/precision 
(confidence interval); 
statistical significance  
 
 
14. Clinical/public health 
importance of the result 
(explain) for the source 
population and wider 
populations  
 
 
15. Overall judgment of 
internal validity (good, 
fair, poor – explain)  
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16. External validity: 
applicability of findings 
to other populations 
beyond the source 
population  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Critical appraisal table documenting 
data items extracted from each of the articles 
included in this systematic review. 
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III. RESULTS| 
Search Results 
 A complete list of the search results generated from the initial PubMed search terms 
selected for this systematic review is available in the appendix (Appendix, “PubMed 
Literature Search”).  The search yielded 13 articles, to which the eligibility criteria were 
applied.  Three articles were determined to be eligible for this systematic review, and the 
results of each are presented in the format of a Results Table.  Each article employed quality 
improvement methodology, two using this methodology alone and one using quality 
improvement methodological principles in combination with principles similar to those of a 
randomized clinical trial.  The results of each study demonstrated that the efforts of the 
quality improvement initiative positively affected the outcome measured in each.  The 
quality improvement initiatives each comprised different components, with the 
corresponding outcomes measured by each differing accordingly.  They included the 
following: the implementation of an asthma pathway in a community emergency department 
that had already been successfully implemented at a tertiary care medical center; initiation of 
a program designed to improve pediatric asthma care by implementing a quality 
improvement project aimed at changing emergency room care; and implementation of an 
improvement collaborative aimed at reducing health care utilization by pediatric asthmatics. 
Results Tables 
1. Citation (JAMA 
style) 
 
Kercsmar CM, Beck AF, Sauers-Ford H, Simmons J, Wiener B, Crosby L, 
Wade-Murphy S, Schoettker PJ, Chundi PK, Samaan Z, Mansour M. 
“Association of an Asthma Improvement Collaborative With Health Care 
Utilization in Medicaid-Insured Pediatric Patients in an Urban Community.”  
JAMA Pediatr. 2017 Nov 1; 171(11):1072-1080. doi: 
10.1001/jamapediatrics.2017.2600. 
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2. Study question 
and research design  
 
This paper summarizes the methods and findings that study investigators 
discovered in response to the following research question: Is implementation 
of a hospital-driven quality improvement initiative associated with a 
reduction in acute asthma-related health care utilization in a population of 
Medicaid-insured pediatric patients?  The research design utilizes 
traditionally-accepted quality improvement concepts and methods, e.g. small 
clinical practice change implementation followed by use of the plan-do-
study-act cycles with interrupted time-series data analysis.  That is, the 
design of the study does not fall within a single category of the most 
common design methodologies presently accepted.  However, this study’s 
methods, and other studies of its type, are invaluable in developing an 
understanding of the role of quality improvement initiatives in affecting 
health care delivery, practice, and outcomes, and it stands to be argued that 
this type of study, while non-traditional, should be critically appraised using 
the same standards as studies that utilize the more traditional methods.    
3. Study population 
(descriptive: 
demographics, 
eligibility criteria) 
and how chosen 
(volunteers, 
recruitment, 
tertiary care clinics, 
population-based, 
etc) 
 
Of the children that comprised the source population, only those who were 
Medicaid-insured were included as subjects to which the quality 
improvement initiatives were applied.  By and large, the way in which the 
study population was chosen can be classified as population-based, with 
children with asthma who received care within the CCHMC system serving 
as the source to which further eligibility criteria (i.e. Medicaid-insured only) 
were applied.  Importantly, however, the authors do not describe the process 
by which insurance providers for each child included in the quality 
improvement initiative were identified as the Medicaid-type.  Also of 
importance, particularly for considerations of external validity and 
applicability later on in the appraisal process, demographic information for 
the study population in excess of age and insurance type is not provided.  
Because the study applies quality improvement methodology, it is exempt 
from certain standards of human subjects research, namely IRB approval and 
informed consent.  This can, in many ways, be viewed as a major limitation 
of this research methodology; it stops readers short of being able to make 
statements, perhaps, about relevance for clinical practices in other diverse 
settings, for example.  Regardless, the key takeaways, of far as the study 
population is concerned, are that: 1) subjects to which the quality 
improvement methods were applied were between the ages of 2 and 17, 2) 
diagnosed with asthma; 3) Medicaid-insured; and 4) receiving care at at least 
one of the four centers/practice locations within the CCHMC listed above. 
 
Because of its direct effect on so many other parts of the appraisal process, it 
seems appropriate to begin discussing the details of what this particular 
quality improvement methodology entailed.  Called the Asthma 
Improvement Collaborative, the initiative was framed using what the authors 
refer to as the chronic care model and implemented using quality 
improvement principles and methods.  The people who framed and executed 
the initiative created a multidisciplinary team consisting of the following: 
hospitalist, primary care, and community pediatricians; pediatric 
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pulmonologists and allergists; emergency department physicians; pediatric 
residents; social workers; respiratory therapists; nurses; care coordinators; 
pharmacists; project managers; QI consultants; and representatives from 
Medicaid managed care organizations and the Cincinnati Health Department 
school health program.  This team first created a key driver diagram that 
included variables thought to most affect health care utilization by the target 
population.  This served as the framework for which team members began 
creating small scale improvement ideas that they would eventually 
implement.  As it serves as a clear summary of the outcome the quality 
improvement initiative hoped to have, the key driver diagram follows below. 
 
 
Interventions were planned based on the key drivers identified.  The authors 
document the specific interventions they implemented clearly (and they are 
therefore not summarized here).  Interventions were implemented in a three 
phase way: phase 1 consisted of improvement activities targeting inpatient 
care, phase 2 focused on changes related to outpatient care, and phase 3 
focused on community-based care and partnerships.  
4. Measurement (of 
exposure/interventi
on; outcomes; 
potential 
confounders): 
reliability and 
validity of 
measurement 
instruments; how 
measurements were 
performed; include 
blinding if needed) 
 
Primary outcomes: Rates of asthma-related hospitalizations and emergency 
department visits by Medicaid-insured children and adolescents aged 2 to 17 
living in Hamilton County.  The baseline period to which subsequent rates 
are compared were the rates in year 2007 to 2009, as this was three years 
before the launch of the 2015 strategic plan.  The authors note that accurate 
and complete data from enrollment from the state Medicaid office became 
available in 2007, too.  In a sense the quality of being Medicaid-insured can 
reasonably be considered the exposure.  Though, using the word reasonably 
in any part of a critical appraisal is probably a bad sign and should be met 
with caution.  Here, though, measurement of this exposure is through a 
Medicaid enrollment database.  Consequently, there could be risk of bias, as 
the authors do not detail their system for crosschecking the tens of thousands 
of patients who have asthma and who are Medicaid-insured.  Alternatively, 
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the fact that the authors do not elaborate could be totally appropriate and 
confusion due only to this reader’s relative inexperience with the medical 
information technology. Hospitalization and ED data were obtained from 
hospital administrative databases and were reported per 10000 Medicaid 
enrollees.  Asthma-related visits were identified using International 
Classification of Diseases, Ninth Edition (ICD-9) codes with asthma as the 
primary code, or a specified set of respiratory diseases as the primary 
diagnosis with asthma as the secondary diagnosis. 
 
Secondary outcomes: The percentage of patients with an asthma-related 
rehospitalization or ED revisit within 30 days of a hospital discharge and the 
percentage of CCHMC primary care patients with well-controlled asthma, 
defined as an ACT score greater than 19. 
 
Changes over time: Tracked on annotated run charts and statistical process 
control charts.  Standard industry criteria were used to differentiate between 
random, common-cause variations and significant, special-cause changes 
attributable to the interventions.  Primary statistical process control charts 
revealed a rolling 12-month mean for the rate of asthma-related 
hospitalizations and ED visits.  This type of chart was used to blunt the 
potential effect of seasonality.  Data autocorrelation was overcome using 
segmented regression analysis, modeling time-series data to draw 
conclusions about effects across phases. 
5. Results: 
magnitude and 
direction (point 
estimate); random 
error/precision 
(confidence 
interval); statistical 
significance  
 
N= 36,000 children and adolescents with asthma in Hamilton County 
(source population). 
n= 13,000 children and adolescents with asthma in Hamilton County who 
were Medicaid-insured; 6,000 children and adolescents with asthma in 
Hamilton County who were Medicaid-insured and cared for in CCHMC 
primary care clinic practices. 
The results of this quality improvement initiative are presented according to 
the 3 phases during which the interventions were implemented. 
Phase 1: Inpatient setting; main intervention here was what the authors call 
the “medication-in-hand intervention.” 
-Percentage of patients discharged from the hospital with a 30-day supply of 
inhaled controller medications increased from 50% in May 2008 to 90% in 
May 2010. 
-Percentage of patients discharged with a short course of oral corticosteroids 
increased from 0% to 70% by March 2011. 
-Percentage of patients re-hospitalized or returning to ED within 30 days of 
hospitalization decreased by 41%, from 12% to 7%. 
Phase 2: Outpatient setting; main intervention focused on baseline asthma 
control of CCHMC primary care patients.  Interventions included ensuring 
Asthma Control Test (ACT) scores were collected, and that patients were 
provided with asthma action plans.  This phase also included the care 
coordination program. 
-By the end of June 2015, 763 had been enrolled in asthma care coordination 
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(look into what the details of this are for systematic review’s completion); 
394 had graduated, and 345 were offered and received medication delivery. 
-Percentage of primary care patients with well-controlled asthma increased 
from 48% to 54%. 
Phase 3: Community setting; interventions focused on enhancing screenings 
and communication. 
-By the initiative’s end, more than 80% of Cincinnati public school students 
with asthma were screening using the ACT, and those with suboptimal 
scores (indicative of poorly controlled asthma) were referred to their existing 
or new medical home. 
Authors note that their phased approach to intervention implementation 
positively contributed to the improvements. 
Asthma-related hospitalizations decreased from 8.1 (95% CI, 7.7-8.5) to 4.7 
(95% CI, 4.3-5.1) per 10000 in-county Medicaid patients per month, a 41.8 
% (95% CI, 41.7%-42.0%) relative reduction. 
Asthma-related ED visits decreased from 21.5 (95% CI, 20.6-22.3) to 12.4 
(95% CI, 11.5-13.2) per 10000 in-county Medicaid patients per month, a 
42.4% (95% CI, 42.2%, 42.6%) relative reduction. 
Absolute decreases in the rolling 12-month mean (per 10000 Medicaid-
enrollees) were 3.4 (95% CI, 3.3-3.5) for asthma-related hospitalizations, 
and 9.1 (95% CI, 9.0-9.2) for ED visits. 
From the regression model, the authors estimate that during the last year of 
the project (2015), improvements were associated with a reduction of 153 
hospitalizations and 318 ED visits.  
 
 
1. Citation (JAMA style) 
 
Krishnan JA, Martin MA, Lohff C, Mosnaim GS, Margellos-Anast H, 
DeLisa JA, McMahon K, Erwin K, Zun LS, Berbaum ML, McDermott 
M, Bracken NE, Kumar R, Margaret Paik S, Nyenhuis SM, Ignoffo S, 
Press VG, Pittsenbarger ZE, Thompson TM; CHICAGO Plan 
consortium.   “Design of a pragmatic trial in minority children 
presenting to the emergency department with uncontrolled asthma: The 
CHICAGO Plan.” Contemp Clin Trials. 2017 Jun; 57:10-22. doi: 
10.1016/j.cct.2017.03.015. Epub 2017 Mar 31. 
2. Study question and 
research design  
 
The authors of this study note that Black and other minority children 
with asthma are 2-3 times more likely than white children to develop 
acute asthma and to, scarily, die from its direct complications.  They 
highlight the fact that this evidence exists despite evidence-based 
asthma management guidelines that have been developed and that are 
currently in place.  This knowledge led them to develop the present 
study which investigates how quality improvement interventions affect 
asthma-related outcomes.  Called “the CHICAGO Plan” (Coordinated 
Healthcare Interventions for Childhood Asthma Gaps in Outcomes), 
the study compares outcomes in children 5 to 11 presenting to the 
emergency department (ED) with acute asthma who received care 
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within one of three categories of interventions: 1) an ED-focused 
intervention to improve quality of care upon discharge to home; 2) #1 
with the addition of a home-based community health worker-led 
intervention; and 3) enhanced but usual care.  Primary outcomes 
included the following: for children, data collected from the Patient 
Reported Outcomes Measurement Information System (PROMIS) 
Asthma Impact Scale and, for caregivers, data collected from the 
Satisfaction with Participation in Social Roles, each completed at 6 
months after care under the designated intervention.  Importantly, this 
is described as a randomized, pragmatic multicenter trial with 3 arms 
represented by each of the intervention categories above.  The study 
was stake-holder supported; key stakeholders helped develop and 
implement the study methods and interventions.  Given randomization, 
the potential for this data to be valid is present and exciting, as most 
studies investigating the implementation of the quality improvement 
methodology are not randomized.  In light of the implications this study 
could have on the results reported in this systematic review, it stands to 
reason that the credibility of this presumed randomization (in addition 
to other parts of the article most commonly appraised) should be 
carefully and critically appraised.    
3. Study population 
(descriptive: 
demographics, eligibility 
criteria) and how chosen 
(volunteers, recruitment, 
tertiary care clinics, 
population-based, etc) 
 
Children and caregivers were recruited from EDs in 6 medical centers 
serving individuals from the west and the south sides of Chicago.  The 
medical centers included the following: Ann & Robert H. Lurie 
Children’s Hospital, Sinai Health System, John H. Stroger Jr. Hospital 
of Cook County Health & Hospitals System, Rush University Medical 
Center, University of Chicago Comer Children’s Hospital & the 
University of Illinois Hospital & Health Sciences System.   
 
In order to be eligible for the study, participants had to meet to the 
following criteria: 
1) Age 5-11; 
2) Presenting to the ED, urgent care center, or observation unit at a 
participating clinical center;  
3) Treated with at least one dose of an inhaled or nebulized short-acting 
bronchodilator (quick-relief medication); 
4) Treated with a systemic corticosteroid; 
5) Child and caregiver approached after at least 1 hour after receipt of 
the first dose of quick-relief medication or systemic corticosteroids, 
whichever occurred first; 
6) Diagnosis of asthma exacerbation by the treating clinician;  
7) Treating ED clinician indicates that the patient is likely to be 
discharged to home; and 
8) Caregiver reports that English or Spanish is the preferred language at 
home. 
 
Children were excluded from the study if they met any of the following 
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criteria: 
1) Caregiver declines to provide informed consent or child declines to 
provide assent; 
2) Child is discharged to another location other than home;  
3) Child or another member of the child’s primary household is a 
current or previous participant in the CHICAGO Plan; 
4) Child is enrolled in another study involving a health-related 
intervention; 
5) A community health worker is already visiting the home as part of 
another program; 
6) Child is expected to move out of Chicago within the next 6 months; 
or 
7) Child does not reside in Chicago. 
Beyond these inclusion and exclusion criteria, demographic 
information on study participants is not provided.  This is where, to 
some degree, I feel that the randomization claim breaks down.  A 
typical, methodologically sound randomized trial would almost never 
not include a Table 1 detailing the basic demographic characteristic of 
its participants.  To me, this aspect of the trial places more in line with 
population-based, more quality improvement methods-style research, 
which is not a bad thing and is still useful for answering this systematic 
review’s question, but is an important distinction to make, especially 
for, later, drawing conclusions about the study’s internal validity. 
4. Measurement (of 
exposure/intervention; 
outcomes; potential 
confounders): reliability 
and validity of 
measurement 
instruments; how 
measurements were 
performed; include 
blinding if needed) 
 
Outcomes were evaluated on enrollment (baseline, i.e. prior to 
randomization) and at each follow-up visit (1 month, 3 month, 6 month, 
and 12 month).  Baseline and 6 month outcome data were collected in-
person by trained research staff members who were not involved in the 
quality improvement initiative.  The remaining outcome data were 
collected by trained research staff by telephone.  Each research staff 
member involved in the outcome data collection process was masked to 
patients’ assigned treatment arm. 
 
Co-primary outcomes: consisted of a primary outcome for the patient 
and a primary outcome for the caregiver.  The co-primary outcomes 
were measured using the Patient-Reported Outcomes Measurement 
System (PROMIS).  Two PROMIS measures, in particular, were 
selected: 1) the 8-item Asthma Impact Scale, used to assess the effect 
of asthma on the patient’s quality of life, and 2) the 4-item Satisfaction 
with Participation in Social Roles scale, used to assess the effects of the 
intervention on the caregiver’s level of satisfaction with his or her 
activities of daily living in the past 7 days. 
 
There are several secondary outcomes for which data were collected; 
however, they are not detailed here, as none is the central focus of the 
investigators’ research question. 
5. Results: magnitude and 
direction (point estimate); 
Presently, there are no data available for this study.  The point of this 
  A. Webb 
30 
 
random error/precision 
(confidence interval); 
statistical significance  
 
paper, from the authors’ perspective, was to present and explain the 
components of their quality improvement initiative, including, 
importantly, how it was developed, the rationale for the steps taken in 
its development, and what steps were involved in the implementation 
process.  The results of the study are to be published at a later date. 
 
1. Citation (JAMA 
style) 
 
Walls TA, Hughes NT, Mullan PC, Chamberlain JM, Brown K. 
“Improving Pediatric Asthma Outcomes in a Community Emergency 
Department.”  Pediatrics. 2017 Jan; 139(1). pii: e20160088. doi: 
10.1542/peds.2016-0088. Epub 2016 Dec 8. 
2. Study question and 
research design  
 
The significance and background the authors offer highlight the 
importance of this issue and studying ways to change the current state of 
practice.  Specifically, they note that hundreds of thousands of pediatric 
patients with asthma present for care of acute asthma exacerbations in the 
setting of a community emergency department (ED), i.e. an emergency 
department that is both not associated with an academic medical center 
and one that is not specialized in providing care for children under the age 
of 18.  Studies have shown that, with large numbers of pediatric 
asthmatics presenting for acute care in the face of limited resources and 
provider knowledge in community EDs, a disproportionate number of 
management errors occur compared to management of the presenting 
problem in tertiary care settings.  Not only that, but studies have also 
shown that pediatric patients presenting to community emergency 
departments for acute asthma management experience poorer health 
outcomes, a fact that, especially considering the aforementioned large 
numbers of patients comprising this subgroup, is highly concerning.  The 
authors of this study designed and implemented a quality improvement 
initiative in a community hospital emergency department in an attempt to 
address this issue.  Specifically, the authors of the study, providers at a 
tertiary care emergency medical center, developed a partnership with 
providers at a community emergency medical center that allowed 
implementation of a quality improvement initiative aimed at reducing the 
number of pediatrics patients with asthma who required transfer to a 
tertiary medical center for continued care after their initial presentation.  
The providers from the community emergency center were also 
motivated, in part, by a recent completion of National Pediatric Readiness 
Survey.  Details of this quality improvement initiative’s study design 
included the following: the authors’ collaboration with a multidisciplinary 
team of providers at the community ED; and adaptation of a national 
guidelines supported pediatric asthma pathway aimed at improving care 
of pediatric asthma patients in the community ED setting by introducing 
an asthma score, increasing the proportion of patients receiving steroids, 
decreasing time to steroid administration, and decreasing the number of 
patients who need transfer to a tertiary medical center for additional 
management.  The authors state that they successfully implemented this 
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national guideline supported asthma pathway to improve care of pediatric 
asthmatics in their home (tertiary center) institution.  For clarity, it should 
be stated that, because the pathway was supported by national guidelines, 
it was evidence-based.  
3. Study population 
(descriptive: 
demographics, 
eligibility criteria) and 
how chosen 
(volunteers, 
recruitment, tertiary 
care clinics, 
population-based, etc) 
 
The process of obtaining the study population from the source can be 
summarized as including the following: 
1) Chart review of all patients age 2 to 17 years who presented to the 
community ED within the timeframe of the study’s start date (see below); 
2) Review of the initial clinical impression documented by the medical 
provider in the electronic health record (EHR); 
3) Inclusion of patients only if the provider documented a clinical 
impression of “wheezing,” “asthma,” or “bronchospasm.”  The rationale 
for eligibility criteria based, in large part, on information documented in 
the clinical impression section of the EHR as opposed to that documented 
in the chief complaint section or use of documented International 
Classification of Diseases, Ninth Revision (ICD9) codes was that the 
authors found that the chief complaints were not sensitive enough, and 
that ICD9 codes and discharge diagnoses were not specific, often 
including diagnoses of asthma or wheezing for a patient whose chart 
provided no other evidence of asthma as the chief complaint and no 
documented respiratory physical exam signs that would be consistent with 
this diagnosis. 
 
The authors took part in the chart review of potential study subjects 12 
months before implementation of the asthma pathway, and 19 months 
after its implementation.   
4. Measurement (of 
exposure/intervention; 
outcomes; potential 
confounders): 
reliability and validity 
of measurement 
instruments; how 
measurements were 
performed; include 
blinding if needed) 
 
Here, again, it is helpful to review what the authors of this study did and 
how they did it. 
Intervention implemented: an evidence-based pediatric asthma pathway 
that mirrored one already implemented at the authors’ institution and that 
was designed by ED providers and hospitalist divisions at this institution 
in accordance with best evidence clinical practice.  The intervention 
implemented this quality improvement intervention by providing decision 
support in a way that was familiar and helpful to members of the 
community emergency department staff.  Specifically, the community ED 
already had evidenced-based practice pathways for other common 
diagnoses, such as sepsis, myocardial infarction, and pneumonia, etc. that 
they found useful and were successful in following.  This study’s 
implementation process capitalized off of this preexisting knowledge by 
using implementation techniques similar to the ones staff members of the 
community ED noted were effective.  Another strategy for 
implementation included use of change concepts for standardization, 
development of operational definitions, and moving steps in a process 
closer together.  They define a change concept as an “approach to change 
found to be useful in developing specific ideas for changes that lead to 
improvement.”  Measurement of key components of the asthma pathway 
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implemented can be summarized as including the following: 
1) Documentation of an asthma score: components of the score were 
adapted from several previously validated scores and modified to allow 
easier communication between physicians, nurses, and respiratory 
therapists in the ED.  Scores range from 0 to 10, with a score greater than 
or equal to 4 considered moderate to severe. 
2) Application of the concept of moving steps in a process closer together: 
provided nurse-initiated therapies for patients, including early use of 
bronchodilators and corticosteroids. 
3) Disciplinary partnership between key stakeholders which included: 
nurses, respiratory therapists, pharmacists, physicians, nurse educators, 
and the medical director. 
4) Before implementation, a meeting took place to discuss the best way 
for implementation into the community ED, and to discuss potential 
barriers to implementation: opted to implement pathway into EHR but 
split it into a provider and triage order set in a way that built on and 
mirrored current evidence-based care practices already in place for other 
conditions in the ED, as noted briefly above. 
5) Adjustments to the asthma pathway to facilitate compliance in the 
community ED included the following: increasing the availability of 
respiratory therapists in the ED to administer multiple doses of 
bronchodilators to patients with severe asthma; making additional 
medications available from the pharmacy; moving a medication 
dispensing system to the triage area for earlier initiation of treatment. 
6) Meeting with staff members of the community ED to discuss the 
evidence supporting the asthma pathway. 
7) A nurse from the authors’ home institution met with nurse educators 
from the community ED to train them on assigning an asthma score; these 
nurse educators then trained nursing staff at the community ED on 
assigning an asthma score and on the details of the asthma pathway.  
Nurses also received a quick reference card with the asthma scoring 
system. 
8) Two study investigators presented the asthma pathway to ED providers 
at physician staff meetings to familiarize them with the pathway.  One 
investigator worked with the community ED pharmacist to ensure proper 
dosing and availability of medications in the order sets.  An investigator 
also met with the community ED information technologist to assist in 
incorporating the pathway into the order sets. 
9) Intervention was implemented in August 2013. 
10) Nurses received continued education on asthma scoring at annual 
skills days. 
11) Community ED staff were surveyed for feedback on pathway 
implementation in March of 2014. 
 12) Survey results and preliminary outcome measures were presented to 
community ED physicians in May of 2014. 
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Process measures included the following: the proportion of children who 
had an asthma score recorded; the proportion of children who received 
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steroids; for those children who received steroids, time from triage arrival 
to steroid administration. 
 
Outcome measures included the following: the proportion of children who 
needed transfer to an outside hospital for additional care.  As a balancing 
measure, the proportion of patients with asthma-related visits to the 
community ED within 7 days of the patient’s initial ED visit was 
examined.   
5. Results: magnitude 
and direction (point 
estimate); random 
error/precision 
(confidence interval); 
statistical significance  
 
N= 724 patients (4.4% of the total number of patients aged 2-17 who 
presented to the community ED during the study timeframe); 289 of these 
patients were included during the baseline or pre-intervention 
implementation period; and 435 of these patients were included after the 
intervention was implemented. 
 
64% of patients were assigned an asthma score after pathway 
implementation. 
 
During the baseline period, 60% of patients received corticosteroids 
during their ED visit; after pathway implementation, 76% received 
steroids during their ED visit (OR 2.2; 95% CI, 1.6-3.0; p<0.0001). 
 
After pathway implementation, the mean time to steroid administration 
decreased significantly, from 196 minutes to 105 minutes (p=0.00001). 
 
Significantly fewer patients needed transfer for additional care after the 
pathway was implemented (10% vs. 14%, OR 0.63, CI 0.40-0.99, 
p=0.046). 
 
There were no significant differences in return rates for patients seen 
during the baseline, pre-intervention period and those seen after pathway 
implementation (2.8% vs. 1.1%, p=0.12). 
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IV. DISCUSSION| 
Findings 
 The main purpose of this systematic review was to methodically search and review the 
literature in order to better understand the following key questions: What types of quality 
improvement initiatives are clinicians who provide care for the pediatric asthma population 
currently undertaking?  What variables determine which quality improvement initiatives are 
successfully implemented, and what effect does this implementation have on health 
outcomes?  Generally speaking, the results suggest that, overall, quality improvement 
initiatives that aim to address current management practices of pediatric patients with asthma 
tend to have large, positive influences on outcomes.  The challenges providers face 
oftentimes are in the form of deciding which variables the initiative should address, in 
generating buy-in from key stakeholders, and, closely related to generating buy-in, finding 
ways to incorporate concerns identified by key stakeholders in the developmental stages of 
the quality improvement process.  A key variable determining the success of implementation 
is the degree to which leaders of the quality improvement initiative are able to gain key 
stakeholder interest, and, by the same token, the level to which the initiative is able to 
address parts of the care process that key stakeholders identify as important.   
The study conducted by Kercsmar, Beck, Sauers-Ford, and Simmons et al. sought to 
determine whether implementation of a hospital-driven quality improvement initiative was 
associated with a reduction in acute asthma-related health care utilization in a population of 
Medicaid-insured pediatric patients.  The research design utilized traditionally-accepted 
quality improvement concepts and methods, e.g. small clinical practice change 
implementation followed by use of the plan-do-study-act cycles with interrupted time-series 
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data analysis.  The study’s source population included children age 2 to 17 with asthma who 
received inpatient, outpatient, and community care within the Cincinnati Children’s Hospital 
Medical Center (CCHMC) from January 1, 2010 through December 31, 2015.  CCHMC is 
located in Hamilton County, Ohio; it is an academic medical center location in an urban 
setting.  Called the Asthma Improvement Collaborative, the initiative was framed using what 
the authors refer to as the chronic care model and implemented using quality improvement 
principles and methods.   
Investigators who framed and executed the initiative created a multidisciplinary team 
consisting of the following: hospitalist, primary care, and community pediatricians; pediatric 
pulmonologists and allergists; emergency department physicians; pediatric residents; social 
workers; respiratory therapists; nurses; care coordinators; pharmacists; project managers; QI 
consultants; and representatives from Medicaid managed care organizations and the Cincinnati 
Health Department school health program.  This team first created a key driver diagram that 
included variables thought to most affect health care utilization by the target population.  This 
served as the framework for which team members began creating small scale improvement ideas 
that they would eventually implement.   
 Interventions were planned based on the key drivers identified, and implemented in a 
three phase way: phase 1 consisted of improvement activities targeting inpatient care, phase 2 
focused on changes related to outpatient care, and phase 3 focused on community-based care and 
partnerships.  Several interventions were implemented (a complete list of interventions can be 
found in the appendix).  Primary outcomes included rates of asthma-related hospitalizations and 
emergency department visits by Medicaid-insured children and adolescents aged 2 to 17 living in 
Hamilton County.  The baseline period to which subsequent rates are compared were the rates in 
  A. Webb 
37 
 
year 2007 to 2009, as this was three years before the launch of the 2015 strategic plan.  
Secondary outcomes included the percentage of patients with an asthma-related rehospitalization 
or ED revisit within 30 days of a hospital discharge and the percentage of CCHMC primary care 
patients with well-controlled asthma, defined as an ACT score greater than 19.   
 The results of this quality improvement initiative are presented according to the 3 phases 
during which the interventions were implemented: 
Phase 1: Inpatient setting; main intervention here was what the authors call the “medication-in-
hand intervention.”  The percentage of patients discharged from the hospital with a 30-day 
supply of inhaled controller medications increased from 50% in May 2008 to 90% in May 2010.  
The percentage of patients discharged with a short course of oral corticosteroids increased from 
0% to 70% by March 2011.  The percentage of patients re-hospitalized or returning to the ED 
within 30 days of hospitalization decreased by 41%, from 12% to 7%. 
Phase 2: Outpatient setting; main intervention focused on baseline asthma control of CCHMC 
primary care patients.  Interventions included ensuring Asthma Control Test (ACT) scores were 
collected, and that patients were provided with asthma action plans.  This phase also included the 
care coordination program.  By the end of June 2015, 763 had been enrolled in asthma care 
coordination (look into what the details of this are for systematic review’s completion); 394 had 
graduated, and 345 were offered and received medication delivery.  The percentage of primary 
care patients with well-controlled asthma increased from 48% to 54%. 
Phase 3: Community setting; interventions focused on enhancing screenings and communication.  
By the initiative’s end, more than 80% of Cincinnati public school students with asthma were 
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screening using the ACT, and those with suboptimal scores (indicative of poorly controlled 
asthma) were referred to their existing or new medical home. 
The authors note that their phased approach to intervention implementation positively 
contributed to the improvements.  Asthma-related hospitalizations decreased from 8.1 (95% CI, 
7.7-8.5) to 4.7 (95% CI, 4.3-5.1) per 10000 in-county Medicaid patients per month, a 41.8 % 
(95% CI, 41.7%-42.0%) relative reduction.  Asthma-related ED visits decreased from 21.5 (95% 
CI, 20.6-22.3) to 12.4 (95% CI, 11.5-13.2) per 10000 in-county Medicaid patients per month, a 
42.4% (95% CI, 42.2%, 42.6%) relative reduction.  Absolute decreases in the rolling 12-month 
mean (per 10000 Medicaid-enrollees) were 3.4 (95% CI, 3.3-3.5) for asthma-related 
hospitalizations, and 9.1 (95% CI, 9.0-9.2) for ED visits.  From the regression model, the authors 
estimate that during the last year of the project (2015), improvements were associated with a 
reduction of 153 hospitalizations and 318 ED visits. 
 The study conducted by Krishnan, Martin, Lohff, and Mosnaim et al. investigates how 
quality improvement interventions affect asthma-related outcomes in the context of evidence 
which suggests that Black and other minority children with asthma are 2-3 times more likely 
than white children to develop acute asthma and to, scarily, die from its direct complications.  
Called “the CHICAGO Plan” (Coordinated Healthcare Interventions for Childhood Asthma Gaps 
in Outcomes), the study compares outcomes in children 5 to 11 presenting to the emergency 
department (ED) with acute asthma who received care within one of three categories of 
interventions: (1) an ED-focused intervention to improve quality of care upon discharge to home; 
(2) the ED-focused intervention with the addition of a home-based community health worker-led 
intervention; and (3) enhanced but usual care.  Primary outcomes included the following: for 
children, data collected from the Patient Reported Outcomes Measurement Information System 
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(PROMIS) Asthma Impact Scale and, for caregivers, data collected from the Satisfaction with 
Participation in Social Roles, each completed at 6 months after care under the designated 
intervention.  Importantly, this is described as a randomized, pragmatic multicenter trial with 3 
arms represented by each of the intervention categories above.  The study was stake-holder 
supported; key stakeholders helped develop and implement the study methods and interventions.   
 The ED-focused intervention targeted improving the quality of care of an ED discharge.  
The main quality improvement change implemented included a paper-based decision support and 
communication tool, called the CHICAGO Action Plan after Emergency department discharge, 
or CAPE tool.  The purpose of the CAPE tool was to provide support of guideline recommended 
asthma care on ED discharge, including but not limited to the following: a course of systemic 
corticosteroids, daily use of inhaled corticosteroids or other controller medication, as needed use 
of inhaled quick-relief medication, assessment and teaching of appropriate inhaler use technique, 
arrangement of post-discharge follow-up, and counseling to avoid known asthma triggers at 
home.  A very important aspect of the CAPE tool, as the authors note, is its culturally-tailored 
and communication-appropriate content, components of the tool that were developed over three 
phases: 1) defining design requirements, 2) prototyping and refining the communication tool, and 
3) evaluating stakeholder preferences for the new tool with direct comparison to the 
communication tool already in place.  The authors note that, following these three phases of 
development, they created a communication tool that took into account the health literacy of the 
tool’s recipients.  Community health workers, ED physicians and nurses thoroughly collaborated 
in designing the CAPE tool.  Consequently, they were supportive of it.  ED coordinators (i.e. 
study coordinators, or members of the research team) performed the CAPE tool after consulting 
with the patient’s primary ED treatment team.  Understanding of the information included in the 
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CAPE tool by patients and caregivers was ascertained using the teach-back method.  Review of 
the CAPE tool with patients and caregivers was then documented in the chart by the study 
coordinator. 
The ED-plus-home interventions arm of the study aimed to test what effects linking 
community health workers with asthmatic children being discharged home from the ED would 
have on asthma-related outcomes.  Community workers are members of the community who 
serve as liaisons between health care consumers and the health care system.  Participants 
randomly allocated to this arm of the study received the same ED-only intervention described 
above in addition being assigned a community health worker who conducted up to 5 home visits 
over 6 months.  The role of the community health worker was to assist children and their 
caregivers to: 1) implement ED discharge instructions, 2) update the asthma treatment plan with 
input from the patient’s outpatient primary care provider, 3) develop a plan to manage asthma 
during school hours, and 4) develop a feasible plan to avoid triggers at home.  The community 
health workers are trained to promote self-efficacy of patients and caregivers in asthma self-
management.  The details of the selection, training and supervision of community health workers 
are presented. 
The enhanced usual care arm consisted of current practice but with the free MDI teaching 
as described above.  Authors note that stakeholders felt it only fair for all participants in the 
CHICAGO Plan to benefit and some way.  They also recognized the importance of having a 
current practice, i.e. control arm in determining the effectiveness of the interventions comprising 
the active comparator groups.  They worried that, unless there was some sort of attached benefit, 
the existence of this arm would significantly deter patients from entering into the study.  A good 
point that the authors make is that a challenge and perhaps limitation of having a usual care arm 
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is the fact that usual care may not elicit the same clinical practices across different clinical 
centers.  In an attempt to mitigate this, project managers masked to study participant treatment 
arm reviewed the electronic health records of participants to gather information about 
information provided in discharge summaries. 
Co-primary outcomes consisted of a primary outcome for the patient and a primary 
outcome for the caregiver.  The co-primary outcomes were measured using the Patient-Reported 
Outcomes Measurement System (PROMIS).  Two PROMIS measures, in particular, were 
selected: 1) the 8-item Asthma Impact Scale, used to assess the effect of asthma on the patient’s 
quality of life, and 2) the 4-item Satisfaction with Participation in Social Roles scale, used to 
assess the effects of the intervention on the caregiver’s level of satisfaction with his or her 
activities of daily living in the past 7 days.  Presently, there are no data available for this study!  
The point of this paper, from the authors’ perspective, was to present and explain the 
components of their quality improvement initiative, including, importantly, how it was 
developed, the rationale for the steps taken in its development, and what steps were involved in 
the implementation process.  The results of the study are to be published at a later date.  There 
are not yet published results, but this fact diminishes the public health importance of this trial, I 
feel, only marginally.  From this systematic review’s purview, it is clear that very few studies 
answering this type of question exist.  In light of this, this paper’s detail of the development of a 
quality improvement initiative and its implementation across several clinical centers in a 
randomized fashion is of extraordinary public health importance.  While still clinically relevant, 
the implications of this trial for clinical practice are less clear given the fact that results of the 
study are not yet available. 
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The study conducted by Walls, Hughes, Mullan et al. The authors of this study designed 
and implemented a quality improvement initiative in a community hospital emergency 
department in an attempt to address this issue.  Specifically, the authors of the study, providers at 
a tertiary care emergency medical center, developed a partnership with providers at a community 
emergency medical center that allowed implementation of a quality improvement initiative 
aimed at reducing the number of pediatrics patients with asthma who required transfer to a 
tertiary medical center for continued care after their initial presentation.  The providers from the 
community emergency center were also motivated, in part, by a recent completion of National 
Pediatric Readiness Survey.  Details of this quality improvement initiative’s study design 
included the following: the authors’ collaboration with a multidisciplinary team of providers at 
the community ED; and adaptation of a national guidelines supported pediatric asthma pathway 
aimed at improving care of pediatric asthma patients in the community ED setting by introducing 
an asthma score, increasing the proportion of patients receiving steroids, decreasing time to 
steroid administration, and decreasing the number of patients who need transfer to a tertiary 
medical center for additional management.  The authors state that they successfully implemented 
this national guideline supported asthma pathway to improve care of pediatric asthmatics in their 
home (tertiary center) institution.  For clarity, it should be stated that, because the pathway was 
supported by national guidelines, it was evidence-based.   
Approximately 55,000 patients sought care at the community emergency department 
where the initiative’s implementation would eventually take place.  Of these 55,000, 
approximately 20% were <18 years of age and therefore potentially eligible to participate in the 
study.  Intervention implemented: an evidence-based pediatric asthma pathway that mirrored one 
already implemented at the authors’ institution and that was designed by ED providers and 
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hospitalist divisions at this institution in accordance with best evidence clinical practice.  The 
investigators implemented this quality improvement intervention by providing decision support 
in a way that was familiar and helpful to members of the community emergency department 
staff.  Specifically, the community ED already had evidenced-based practice pathways for other 
common diagnoses, such as sepsis, myocardial infarction, and pneumonia, etc. that they found 
useful and were successful in following.  This study’s implementation process capitalized off of 
this preexisting knowledge by using implementation techniques similar to the ones staff 
members of the community ED noted were effective.  Another strategy for implementation 
included use of change concepts for standardization, development of operational definitions, and 
moving steps in a process closer together.  They define a change concept as an “approach to 
change found to be useful in developing specific ideas for changes that lead to improvement.”  
Measurement of key components of the asthma pathway implemented can be summarized as 
including the following: 
(1) Documentation of an asthma score: components of the score were adapted from several 
previously validated scores and modified to allow easier communication between physicians, 
nurses, and respiratory therapists in the ED.  Scores range from 0 to 10, with a score greater than 
or equal to 4 considered moderate to severe. 
(2) Application of the concept of moving steps in a process closer together: provided nurse-
initiated therapies for patients, including early use of bronchodilators and corticosteroids. 
(3) Disciplinary partnership between key stakeholders which included: nurses, respiratory 
therapists, pharmacists, physicians, nurse educators, and the medical director. 
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(4) Before implementation, a meeting took place to discuss the best way for implementation into 
the community ED, and to discuss potential barriers to implementation: opted to implement 
pathway into EHR but split it into a provider and triage order set in a way that built on and 
mirrored current evidence-based care practices already in place for other conditions in the ED, as 
noted briefly above. 
(5) Adjustments to the asthma pathway to facilitate compliance in the community ED included 
the following: increasing the availability of respiratory therapists in the ED to administer 
multiple doses of bronchodilators to patients with severe asthma; making additional medications 
available from the pharmacy; moving a medication dispensing system to the triage area for 
earlier initiation of treatment. 
(6) Meeting with staff members of the community ED to discuss the evidence supporting the 
asthma pathway. 
Results included the following: 724 patients (4.4% of the total number of patients aged 2-17 who 
presented to the community ED during the study timeframe); 289 of these patients were included 
during the baseline or pre-intervention implementation period; and 435 of these patients were 
included after the intervention was implemented.  64% of patients were assigned an asthma score 
after pathway implementation.  During the baseline period, 60% of patients received 
corticosteroids during their ED visit; after pathway implementation, 76% received steroids 
during their ED visit (OR 2.2; 95% CI, 1.6-3.0; p<0.0001).  After pathway implementation, the 
mean time to steroid administration fell significantly, from 196 minutes to 105 minutes 
(p=0.00001).  Significantly fewer patients needed transfer for additional care after the pathway 
was implemented (10% vs. 14%, OR 0.63, CI 0.40-0.99, p=0.046).  There were no significant 
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differences in return rates for patients seen during the baseline, pre-intervention period and those 
seen after pathway implementation (2.8% vs. 1.1%, p=0.12). 
Public Health Importance 
 The evidence from this systematic review both highlights that the implementation of 
quality improvement initiatives can be done successfully, and that, when done successfully, can 
have a considerably large effect on the health outcomes of members of the pediatric asthmatic 
population.  What is more, it demonstrates key variables that help define or predict whether the 
initiative may be a success or failure.  Paying attention to the opinions and perspectives of staff 
members appears to be an important characteristic of an implementation process that will likely 
be successful, as is implementing components of the quality improvement initiative in phases.  
Of all that the evidence suggests, perhaps the most important is the breadth of effect quality 
improvement initiatives can have.  For instance, the quality improvement process methodology 
rests on a significant number of principles of population-health; it aims to ignite small but 
meaningful changes that affect the health of large groups of people.  In the case of pediatric 
asthmatics, individuals who historically have consumed health care at high rates and have 
therefore contributed to its rising cost, changes like adopting  newer versions of communication 
tools, or pairing a family with a community aide following hospital discharge, can go a long 
way.  If anything, the fact that only 3 studies were reviewed points to the fact that not enough is 
being done in this area of research, especially given the potential of this type of work to improve 
the health and delivery of care to others. 
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V. LIMITATIONS & CONCLUSION| 
The results of this systematic review have both clinical and public health importance and 
relevance.  Chiefly, it provides an example of how the quality improvement methodology can be 
effectively implemented, demonstrates that this methodology can, in fact, be done 
systematically, and illustrates the fact that systematic implementation of small scale changes can 
have large effects on outcomes for pediatric asthma patients.  It certainly and excitingly posits 
strength into the idea that quality improvement methods can be employed to help foster better 
health care delivery to this important consumer population.  The main limitation, however, is the 
fact that only three studies were reviewed.  The other limitation is the fact that the person 
conducting this systematic review is a novice, with limited clinical knowledge at this phase of 
my career, in addition to my limited clinical expertise.  Despite these limitations, it seems clear 
that there is not yet enough data available to help clearly formulate answers engendered by this 
very important topic aside from the fact that more work needs to be done. 
APPENDIX 
I. PubMed Literature Search  
Last search performed on 3/15/2018 
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II. QI Interventions 
TABLE 2: Quality Improvement Interventions 
Kercsmar CM, Beck AF, Sauers-Ford H, Simmons J, Wiener B, Crosby L, Wade-Murphy S, Schoettker 
PJ, Chundi PK, Samaan Z, Mansour M. “Association of an Asthma Improvement Collaborative With 
Health Care Utilization in Medicaid-Insured Pediatric Patients in an Urban Community.”  JAMA Pediatr. 
2017 Nov 1; 171(11):1072-1080. doi: 10.1001/jamapediatrics.2017.2600. 
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III. Critical Appraisal Tables 
TABLE 1: Critical Appraisal of Articles Included in Systematic Review  
Tables adapted from PUBH 751: Critical Appraisal of the Health Literature, Fall 2015 Course 
1. Citation (JAMA 
style) 
 
Kercsmar CM, Beck AF, Sauers-Ford H, Simmons J, Wiener B, Crosby L, 
Wade-Murphy S, Schoettker PJ, Chundi PK, Samaan Z, Mansour M. 
“Association of an Asthma Improvement Collaborative With Health Care 
Utilization in Medicaid-Insured Pediatric Patients in an Urban Community.”  
JAMA Pediatr. 2017 Nov 1; 171(11):1072-1080. doi: 
10.1001/jamapediatrics.2017.2600. 
2. Study question 
and research design  
 
This paper summarizes the methods and findings that study investigators 
discovered in response to the following research question: Is implementation 
of a hospital-driven quality improvement initiative associated with a 
reduction in acute asthma-related health care utilization in a population of 
Medicaid-insured pediatric patients?  The research design utilizes 
traditionally-accepted quality improvement concepts and methods, e.g. small 
clinical practice change implementation followed by use of the plan-do-
study-act cycles with interrupted time-series data analysis.  That is, the 
design of the study does not fall within a single category of the most 
common design methodologies presently accepted.  However, this study’s 
methods, and other studies of its type, are invaluable in developing an 
understanding of the role of quality improvement initiatives in affecting 
health care delivery, practice, and outcomes, and it stands to be argued that 
this type of study, while non-traditional, should be critically appraised using 
the same standards as studies that utilize the more traditional methods.    
3. Source 
Population 
 
The study’s source population included children age 2 to 17 with asthma 
who received inpatient, outpatient, and community care within the 
Cincinnati Children’s Hospital Medical Center (CCHMC) from January 1, 
2010 through December 31, 2015.  CCHMC is located in Hamilton County, 
Ohio; it is an academic medical center location in an urban setting.  Most of 
the children seeking care at CCHMC are presumed to be from this area in 
Ohio; the authors state that the center provides care for ~90% of pediatric 
patients residing in Hamilton Co.  The exact number of children with asthma 
and who receive care with the CCHMC system are not specified, but 
children to whom further inclusion/exclusion criteria were applied (and who 
therefore comprise the source population) included those seeking care at the 
following locations: 
1) CCHMC pediatric inpatient unit; 
2) CCHMC general pediatrics primary care clinics; 
3) CCHMC pediatric pulmonary clinics; and 
4) CCHMC emergency department. 
4. Study population 
(descriptive: 
demographics, 
eligibility criteria) 
and how chosen 
(volunteers, 
recruitment, 
Of the children that comprised the source population, only those who were 
Medicaid-insured were included as subjects to which the quality 
improvement initiatives were applied.  By and large, the way in which the 
study population was chosen can be classified as population-based, with 
children with asthma who received care within the CCHMC system serving 
as the source to which further eligibility criteria (i.e. Medicaid-insured only) 
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tertiary care clinics, 
population-based, 
etc) 
 
were applied.  Importantly, however, the authors do not describe the process 
by which insurance providers for each child included in the quality 
improvement initiative were identified as the Medicaid-type.  Also of 
importance, particularly for considerations of external validity and 
applicability later on in the appraisal process, demographic information for 
the study population in excess of age and insurance type is not provided.  
Because the study applies quality improvement methodology, it is exempt 
from certain standards of human subjects research, namely IRB approval and 
informed consent.  This can, in many ways, be viewed as a major limitation 
of this research methodology; it stops readers short of being able to make 
statements, perhaps, about relevance for clinical practices in other diverse 
settings, for example.  Regardless, the key takeaways, of far as the study 
population is concerned, are that: 1) subjects to which the quality 
improvement methods were applied were between the ages of 2 and 17, 2) 
diagnosed with asthma; 3) Medicaid-insured; and 4) receiving care at at least 
one of the four centers/practice locations within the CCHMC listed above. 
 
Because of its direct effect on so many other parts of the appraisal process, it 
seems appropriate to begin discussing the details of what this particular 
quality improvement methodology entailed.  Called the Asthma 
Improvement Collaborative, the initiative was framed using what the authors 
refer to as the chronic care model and implemented using quality 
improvement principles and methods.  The people who framed and executed 
the initiative created a multidisciplinary team consisting of the following: 
hospitalist, primary care, and community pediatricians; pediatric 
pulmonologists and allergists; emergency department physicians; pediatric 
residents; social workers; respiratory therapists; nurses; care coordinators; 
pharmacists; project managers; QI consultants; and representatives from 
Medicaid managed care organizations and the Cincinnati Health Department 
school health program.  This team first created a key driver diagram that 
included variables thought to most affect health care utilization by the target 
population.  This served as the framework for which team members began 
creating small scale improvement ideas that they would eventually 
implement.  As it serves as a clear summary of the outcome the quality 
improvement initiative hoped to have, the key driver diagram follows below. 
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Interventions were planned based on the key drivers identified.  The authors 
document the specific interventions they implemented clearly (and they are 
therefore not summarized here).  Interventions were implemented in a three 
phase way: phase 1 consisted of improvement activities targeting inpatient 
care, phase 2 focused on changes related to outpatient care, and phase 3 
focused on community-based care and partnerships.  
5. Initial 
comparability of 
groups (ie, 
randomization or 
group composition; 
concealment of 
allocation) 
 
This part of the appraisal guide is not applicable to the quality improvement 
research methodology, as there is no randomization of groups and baseline 
characteristics of members of the study population beyond those identified 
during the inclusion/exclusion process are not recorded (a limitation of this 
type of research, as mentioned above).   
6. Drop outs (no 
endpoint data), 
adherence, cross-
overs (other terms: 
attrition; loss to 
follow-up) 
 
This part of the appraisal guide is not applicable to the quality improvement 
research methodology, as this research is conducted in a way that 
systematically implements small scale improvements on a population-level 
followed by assessment of the effect on population-based outcomes. 
7. Potential for 
selection bias (grade 
+ to +++, and 
explain) 
 
+.  For all intents and purposes, selection bias in this type of study is 
negligible, as the processes that often predispose studies to this type of bias 
(i.e. subject recruitment, study arms requiring an allocation procedure, 
randomization, etc.) were not parts of this research.  It is also unlikely that, 
given the discussion about the source and subject population and how each 
were obtained, selection of the group of people to which quality 
improvement interventions were applied actually affected the accuracy of 
results.  
8. Measurement (of 
exposure/interventi
on; outcomes; 
Primary outcomes: Rates of asthma-related hospitalizations and emergency 
department visits by Medicaid-insured children and adolescents aged 2 to 17 
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potential 
confounders): 
reliability and 
validity of 
measurement 
instruments; how 
measurements were 
performed; include 
blinding if needed) 
 
living in Hamilton County.  The baseline period to which subsequent rates 
are compared were the rates in year 2007 to 2009, as this was three years 
before the launch of the 2015 strategic plan.  The authors note that accurate 
and complete data from enrollment from the state Medicaid office became 
available in 2007, too.  In a sense the quality of being Medicaid-insured can 
reasonably be considered the exposure.  Though, using the word reasonably 
in any part of a critical appraisal is probably a bad sign and should be met 
with caution.  Here, though, measurement of this exposure is through a 
Medicaid enrollment database.  Consequently, there could be risk of bias, as 
the authors do not detail their system for crosschecking the tens of thousands 
of patients who have asthma and who are Medicaid-insured.  Alternatively, 
the fact that the authors do not elaborate could be totally appropriate and 
confusion due only to this reader’s relative inexperience with the medical 
information technology. Hospitalization and ED data were obtained from 
hospital administrative databases and were reported per 10000 Medicaid 
enrollees.  Asthma-related visits were identified using International 
Classification of Diseases, Ninth Edition (ICD-9) codes with asthma as the 
primary code, or a specified set of respiratory diseases as the primary 
diagnosis with asthma as the secondary diagnosis. 
 
Secondary outcomes: The percentage of patients with an asthma-related 
rehospitalization or ED revisit within 30 days of a hospital discharge and the 
percentage of CCHMC primary care patients with well-controlled asthma, 
defined as an ACT score greater than 19. 
 
Changes over time: Tracked on annotated run charts and statistical process 
control charts.  Standard industry criteria were used to differentiate between 
random, common-cause variations and significant, special-cause changes 
attributable to the interventions.  Primary statistical process control charts 
revealed a rolling 12-month mean for the rate of asthma-related 
hospitalizations and ED visits.  This type of chart was used to blunt the 
potential effect of seasonality.  Data autocorrelation was overcome using 
segmented regression analysis, modeling time-series data to draw 
conclusions about effects across phases. 
9. Potential for 
measurement bias 
(grade + to +++, 
explain) 
 
+.  Minimal risk of bias given systematic ways of determining exposure, 
intervention and measuring outcomes (Medicaid-insured, asthma-related 
hospitalization or ED visit).  
10. Potential 
confounders (name 
what they are and 
how each was 
controlled: ie, by 
randomization, 
restriction, 
statistical 
adjustment, 
stratification, etc) 
This part of the appraisal guide is not applicable to the quality improvement 
research methodology, as this research is conducted in a way that 
systematically implements small scale improvements on a population-level 
followed by assessment of the effect on population-based outcomes. 
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11. Potential for 
confounding (grade 
+ to +++, explain)  
 
Not applicable here, for the same reason as directly above. 
12. Analysis 
(intention to treat if 
applicable, other 
adjustment) 
 
A change in trend was defined as a change in slope after the intervention 
compared with before the intervention.  Interventions were grouped 
according to their timing within the three phases of project implementation.  
Autoregressive models using the maximum likelihood method were built 
using SAS statistical software.  Predictive values were obtained.  To 
estimate the number of hospitalizations and ED visits avoided because of the 
interventions, two additional models were built and included a negative 
binomial regression model (instead of Poisson) in order to overcome the 
issue of over dispersion.    
 
13. Results: 
magnitude and 
direction (point 
estimate); random 
error/precision 
(confidence 
interval); statistical 
significance  
 
N= 36,000 children and adolescents with asthma in Hamilton County 
(source population). 
n= 13,000 children and adolescents with asthma in Hamilton County who 
were Medicaid-insured; 6,000 children and adolescents with asthma in 
Hamilton County who were Medicaid-insured and cared for in CCHMC 
primary care clinic practices. 
The results of this quality improvement initiative are presented according to 
the 3 phases during which the interventions were implemented. 
Phase 1: Inpatient setting; main intervention here was what the authors call 
the “medication-in-hand intervention.” 
-Percentage of patients discharged from the hospital with a 30-day supply of 
inhaled controller medications increased from 50% in May 2008 to 90% in 
May 2010. 
-Percentage of patients discharged with a short course of oral corticosteroids 
increased from 0% to 70% by March 2011. 
-Percentage of patients re-hospitalized or returning to ED within 30 days of 
hospitalization decreased by 41%, from 12% to 7%. 
Phase 2: Outpatient setting; main intervention focused on baseline asthma 
control of CCHMC primary care patients.  Interventions included ensuring 
Asthma Control Test (ACT) scores were collected, and that patients were 
provided with asthma action plans.  This phase also included the care 
coordination program. 
-By the end of June 2015, 763 had been enrolled in asthma care coordination 
(look into what the details of this are for systematic review’s completion); 
394 had graduated, and 345 were offered and received medication delivery. 
-Percentage of primary care patients with well-controlled asthma increased 
from 48% to 54%. 
Phase 3: Community setting; interventions focused on enhancing screenings 
and communication. 
-By the initiative’s end, more than 80% of Cincinnati public school students 
with asthma were screening using the ACT, and those with suboptimal 
scores (indicative of poorly controlled asthma) were referred to their existing 
or new medical home. 
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Authors note that their phased approach to intervention implementation 
positively contributed to the improvements. 
Asthma-related hospitalizations decreased from 8.1 (95% CI, 7.7-8.5) to 4.7 
(95% CI, 4.3-5.1) per 10000 in-county Medicaid patients per month, a 41.8 
% (95% CI, 41.7%-42.0%) relative reduction. 
Asthma-related ED visits decreased from 21.5 (95% CI, 20.6-22.3) to 12.4 
(95% CI, 11.5-13.2) per 10000 in-county Medicaid patients per month, a 
42.4% (95% CI, 42.2%, 42.6%) relative reduction. 
Absolute decreases in the rolling 12-month mean (per 10000 Medicaid-
enrollees) were 3.4 (95% CI, 3.3-3.5) for asthma-related hospitalizations, 
and 9.1 (95% CI, 9.0-9.2) for ED visits. 
From the regression model, the authors estimate that during the last year of 
the project (2015), improvements were associated with a reduction of 153 
hospitalizations and 318 ED visits.  
 
14. Clinical/public 
health importance 
of the result 
(explain) for the 
source population 
and wider 
populations  
 
The results of this study have both clinical and public health importance and 
relevance.  Chiefly, it provides an example of how the quality improvement 
methodology can be effectively implemented, demonstrates that this 
methodology can, in fact, be done systematically, and illustrates the fact that 
systematic implementation of small scale changes can have large effects on 
outcomes for pediatric asthma patients.  It certainly and excitingly posits 
strength into the idea that quality improvement methods can be employed to 
help foster better health care delivery to this important consumer population. 
15. Overall 
judgment of 
internal validity 
(good, fair, poor – 
explain)  
 
Good.  This study demonstrated a low risk of selection and measurement 
bias, and it was easy to understand and follow what the authors set out to do, 
the steps they took to complete each task, and why they thought the 
conclusions they drew were valid and robust.  
16. External 
validity: 
applicability of 
findings to other 
populations beyond 
the source 
population  
 
This article has excellent capacity to be applied to larger populations.  I may 
even say that, from the standpoint of demonstrating that quality 
improvement principles applied to address a health care delivery problem 
alone, this study applies greatly to several areas and populations within 
medicine.  It will be interesting to learn what other studies offer and 
conclude about the successes or failures of quality improvement method 
implementation! 
 
1. Citation 
(JAMA style) 
 
Krishnan JA, Martin MA, Lohff C, Mosnaim GS, Margellos-Anast H, DeLisa 
JA, McMahon K, Erwin K, Zun LS, Berbaum ML, McDermott M, Bracken 
NE, Kumar R, Margaret Paik S, Nyenhuis SM, Ignoffo S, Press VG, 
Pittsenbarger ZE, Thompson TM; CHICAGO Plan consortium.   “Design of a 
pragmatic trial in minority children presenting to the emergency department 
with uncontrolled asthma: The CHICAGO Plan.” Contemp Clin Trials. 2017 
Jun; 57:10-22. doi: 10.1016/j.cct.2017.03.015. Epub 2017 Mar 31. 
2. Study question 
and research 
design  
The authors of this study note that Black and other minority children with 
asthma are 2-3 times more likely than white children to develop acute asthma 
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 and to, scarily, die from its direct complications.  They highlight the fact that 
this evidence exists despite evidence-based asthma management guidelines 
that have been developed and that are currently in place.  This knowledge led 
them to develop the present study which investigates how quality 
improvement interventions affect asthma-related outcomes.  Called “the 
CHICAGO Plan” (Coordinated Healthcare Interventions for Childhood 
Asthma Gaps in Outcomes), the study compares outcomes in children 5 to 11 
presenting to the emergency department (ED) with acute asthma who received 
care within one of three categories of interventions: 1) an ED-focused 
intervention to improve quality of care upon discharge to home; 2) #1 with the 
addition of a home-based community health worker-led intervention; and 3) 
enhanced but usual care.  Primary outcomes included the following: for 
children, data collected from the Patient Reported Outcomes Measurement 
Information System (PROMIS) Asthma Impact Scale and, for caregivers, data 
collected from the Satisfaction with Participation in Social Roles, each 
completed at 6 months after care under the designated intervention.  
Importantly, this is described as a randomized, pragmatic multicenter trial 
with 3 arms represented by each of the intervention categories above.  The 
study was stake-holder supported; key stakeholders helped develop and 
implement the study methods and interventions.  Given randomization, the 
potential for this data to be valid is present and exciting, as most studies 
investigating the implementation of the quality improvement methodology are 
not randomized.  In light of the implications this study could have on the 
results reported in this systematic review, it stands to reason that the 
credibility of this presumed randomization (in addition to other parts of the 
article most commonly appraised) should be carefully and critically appraised.    
3. Source 
Population 
 
While not explicitly stated, it seems as though the source population, or the 
group of people to whom further inclusion and exclusion criteria were applied, 
consisted of all children age 5 to 11 who presented to the emergency 
department at medical centers pre-designated as participating in this clinical 
trial with initial clinical signs and symptoms consistent with an acute asthma 
exacerbation.  The authors of the study provide the complete list of 
participating medical centers in an article supplement, as well as an in-article 
graphic depiction and table. 
4. Study 
population 
(descriptive: 
demographics, 
eligibility criteria) 
and how chosen 
(volunteers, 
recruitment, 
tertiary care 
clinics, 
population-based, 
etc) 
 
Children and caregivers were recruited from EDs in 6 medical centers serving 
individuals from the west and the south sides of Chicago.  The medical centers 
included the following: Ann & Robert H. Lurie Children’s Hospital, Sinai 
Health System, John H. Stroger Jr. Hospital of Cook County Health & 
Hospitals System, Rush University Medical Center, University of Chicago 
Comer Children’s Hospital & the University of Illinois Hospital & Health 
Sciences System.   
 
In order to be eligible for the study, participants had to meet to the following 
criteria: 
1) Age 5-11; 
2) Presenting to the ED, urgent care center, or observation unit at a 
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participating clinical center;  
3) Treated with at least one dose of an inhaled or nebulized short-acting 
bronchodilator (quick-relief medication); 
4) Treated with a systemic corticosteroid; 
5) Child and caregiver approached after at least 1 hour after receipt of the first 
dose of quick-relief medication or systemic corticosteroids, whichever 
occurred first; 
6) Diagnosis of asthma exacerbation by the treating clinician;  
7) Treating ED clinician indicates that the patient is likely to be discharged to 
home; and 
8) Caregiver reports that English or Spanish is the preferred language at home. 
 
Children were excluded from the study if they met any of the following 
criteria: 
1) Caregiver declines to provide informed consent or child declines to provide 
assent; 
2) Child is discharged to another location other than home;  
3) Child or another member of the child’s primary household is a current or 
previous participant in the CHICAGO Plan; 
4) Child is enrolled in another study involving a health-related intervention; 
5) A community health worker is already visiting the home as part of another 
program; 
6) Child is expected to move out of Chicago within the next 6 months; or 
7) Child does not reside in Chicago. 
Beyond these inclusion and exclusion criteria, demographic information on 
study participants is not provided.  This is where, to some degree, I feel that 
the randomization claim breaks down.  A typical, methodologically sound 
randomized trial would almost never not include a Table 1 detailing the basic 
demographic characteristic of its participants.  To me, this aspect of the trial 
places more in line with population-based, more quality improvement 
methods-style research, which is not a bad thing and is still useful for 
answering this systematic review’s question, but is an important distinction to 
make, especially for, later, drawing conclusions about the study’s internal 
validity. 
5. Initial 
comparability of 
groups (ie, 
randomization or 
group 
composition; 
concealment of 
allocation) 
 
Initial comparability of groups within each arm of the study was difficult to 
determine for the reasons articulated in the cell directly above.  In reading 
further, it’s become clear that the authors devote a relatively large amount of 
space detailing 1) how the study was designed; i.e. the interventions they 
implemented in each of the study arms and 2) how they developed these 
interventions, from the standpoint of how they created the stakeholder team, 
who comprised it, and the rationale for having the stakeholders drive the 
development of the interventions.  Here, I find it helpful to focus on and 
review the former.  Essentially, I’m trying to figure out exactly what the 
authors did and how they did it before moving on to other part of the appraisal 
process. 
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All participants: Receive asthma care per their respective ED clinicians.  In 
addition, CHICAGO Plan ED coordinators provide all participants with two 
metered-dose inhaler (MDI) spacers free of charge and use repeated rounds of 
education and evaluation until the child achieves mastery.  The goal of this 
intervention was to educate children and their caregivers on the proper use of 
MDIs.  Proper MDI use was chosen as an intervention target because most 
quick-relief medications and asthma controller medications are administered 
using this device.  Children were then randomly assigned to one of the three 
arms described below. 
 
ED-only intervention: This ED-focused intervention targeted improving the 
quality of care of an ED discharge.  The main quality improvement change 
implemented included a paper-based decision support and communication 
tool, called the CHICAGO Action Plan after Emergency department 
discharge, or CAPE tool.  The purpose of the CAPE tool was to provide 
support of guideline recommended asthma care on ED discharge, including 
but not limited to the following: a course of systemic corticosteroids, daily use 
of inhaled corticosteroids or other controller medication, as needed use of 
inhaled quick-relief medication, assessment and teaching of appropriate 
inhaler use technique, arrangement of post-discharge follow-up, and 
counseling to avoid known asthma triggers at home.  A very important aspect 
of the CAPE tool, as the authors note, is its culturally-tailored and 
communication-appropriate content, components of the tool that were 
developed over three phases: 1) defining design requirements, 2) prototyping 
and refining the communication tool, and 3) evaluating stakeholder 
preferences for the new tool with direct comparison to the communication tool 
already in place.  The authors note that, following these three phases of 
development, they created a communication tool that took into account the 
health literacy of the tool’s recipients.  Community health workers, ED 
physicians and nurses thoroughly collaborated in designing the CAPE tool.  
Consequently, they were supportive of it.  ED coordinators (i.e. study 
coordinators, or members of the research team) performed the CAPE tool after 
consulting with the patient’s primary ED treatment team.  Understanding of 
the information included in the CAPE tool by patients and caregivers was 
ascertained using the teach-back method.  Review of the CAPE tool with 
patients and caregivers was then documented in the chart by the study 
coordinator. 
 
ED-plus-home interventions: This arm of the study aimed to test what effects 
linking community health workers with asthmatic children being discharged 
home from the ED would have on asthma-related outcomes.  Community 
workers are members of the community who serve as liaisons between health 
care consumers and the health care system.  Participants randomly allocated to 
this arm of the study received the same ED-only intervention described above 
in addition being assigned a community health worker who conducted up to 5 
home visits over 6 months.  The role of the community health worker was to 
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assist children and their caregivers to: 1) implement ED discharge instructions, 
2) update the asthma treatment plan with input from the patient’s outpatient 
primary care provider, 3) develop a plan to manage asthma during school 
hours, and 4) develop a feasible plan to avoid triggers at home.  The 
community health workers are trained to promote self-efficacy of patients and 
caregivers in asthma self-management.  The details of the selection, training 
and supervision of community health workers are presented. 
 
Enhanced usual care: This arm consisted of current practice but with the free 
MDI teaching as described above.  Authors note that stakeholders felt it only 
fair for all participants in the CHICAGO Plan to benefit and some way.  They 
also recognized the importance of having a current practice, i.e. control arm in 
determining the effectiveness of the interventions comprising the active 
comparator groups.  They worried that, unless there was some sort of attached 
benefit, the existence of this arm would significantly deter patients from 
entering into the study.  A good point that the authors make is that a challenge 
and perhaps limitation of having a usual care arm is the fact that usual care 
may not elicit the same clinical practices across different clinical centers.  In 
an attempt to mitigate this, project managers masked to study participant 
treatment arm reviewed the electronic health records of participants to gather 
information about information provided in discharge summaries. 
6. Drop outs (no 
endpoint data), 
adherence, cross-
overs (other 
terms: attrition; 
loss to follow-up) 
 
 
In cases where study participants elected to prematurely discontinue study 
interventions, investigators encouraged completion of outcomes assessment in 
order to analysis according to the intention-to-treat principle.  
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7. Potential for 
selection bias 
(grade + to +++, 
and explain) 
 
 
 
 
++.  Given that all study participants were recruited from a geographic 
location noted to be almost explicitly populated by people of low 
socioeconomic status, it might be challenging to apply the results of this study 
to wider populations, such as those of higher socioeconomic status and those 
of a different race.  Furthermore, it seems likely that, given that almost all 
study participants are poor minorities that the outcome data may be skewed.  
In other words, people of this social and racial background historically accept 
most help given to them as something of good value; people in need will 
likely have much lower standards for accepting a change as an improvement 
than people whose need is not as great.  In this way, patients and caregivers 
included in the study may report a change that would seemingly represent a 
large, positive improvement in the study’s results, but, in fact, the person 
completing the outcomes questionnaire may just be indicating that anything 
was better than what they originally had access to.  Randomization is one way 
that this risk of bias is mitigated, and, as such, a score of ++ was given for the 
potential of selection bias to alter the true results of the study. 
8. Measurement 
(of 
exposure/interven
tion; outcomes; 
potential 
confounders): 
reliability and 
validity of 
measurement 
instruments; how 
measurements 
Outcomes were evaluated on enrollment (baseline, i.e. prior to randomization) 
and at each follow-up visit (1 month, 3 month, 6 month, and 12 month).  
Baseline and 6 month outcome data were collected in-person by trained 
research staff members who were not involved in the quality improvement 
initiative.  The remaining outcome data were collected by trained research 
staff by telephone.  Each research staff member involved in the outcome data 
collection process was masked to patients’ assigned treatment arm. 
 
Co-primary outcomes: consisted of a primary outcome for the patient and a 
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were performed; 
include blinding if 
needed) 
 
primary outcome for the caregiver.  The co-primary outcomes were measured 
using the Patient-Reported Outcomes Measurement System (PROMIS).  Two 
PROMIS measures, in particular, were selected: 1) the 8-item Asthma Impact 
Scale, used to assess the effect of asthma on the patient’s quality of life, and 2) 
the 4-item Satisfaction with Participation in Social Roles scale, used to assess 
the effects of the intervention on the caregiver’s level of satisfaction with his 
or her activities of daily living in the past 7 days. 
 
There are several secondary outcomes for which data were collected; however, 
they are not detailed here, as none is the central focus of the investigators’ 
research question. 
9. Potential for 
measurement bias 
(grade + to +++, 
explain) 
 
+, due largely to the fact that the authors do a thorough job explaining how 
they measured exposure to each of the interventions primary and secondary 
outcomes, and that measurement (of the co-primary outcomes, at least), was 
performed using a tool with the following properties: 1) comparability, with 
measures that have been standardized such that there are common domains 
and metrics across conditions, 2) reliability and validity with domain metrics 
that have reviewed and tested, 3) flexibility in the way it allows information to 
be collected, e.g. by telephone, in person, or via computer adaptive testing, 
and 4) inclusiveness such that all people, regardless of literacy, language or 
physical function can be accommodated, complete the form, and provide data 
that is deemed reliable.  Risk of bias in measuring exposure to the intervention 
is present but minimal; patients and caregivers consented to participate in the 
study and were either exposed to a given intervention or were not, based on 
randomization.  A potential limitation of the randomization process, however, 
is that, following informed consent, neither the study participants nor 
members of the study team were blinded.  This could potentially give way to a 
fair amount of measurement bias.  For example, participants who were 
randomly assigned to be a part of the ED-plus-community health worker arm 
of the trial may subconsciously experience pressure to rate their asthma 
control or quality of life higher because they are aware that these interventions 
should improve these outcomes instead of the interventions causing an 
improvement in these outcomes organically. 
10. Potential 
confounders 
(name what they 
are and how each 
was controlled: ie, 
by 
randomization, 
restriction, 
statistical 
adjustment, 
stratification, etc) 
Unfortunately, the authors do not provide a Table 1.  It is clear that most study 
participants are minority and of low socioeconomic status, which could 
introduce bias on its own, as described above.  However, it remains unclear 
what other characteristics study participants possess, and therefore what 
variables could potentially confound the data.  For what it’s worth, the study is 
a randomized trial, which could potentially mitigate this risk for bias in the 
interpretation of results.  
11. Potential for 
confounding 
(grade + to +++, 
explain)  
 
Unclear, for the reasons described above. 
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12. Analysis 
(intention to treat 
if applicable, 
other adjustment) 
 
Analyses will be conducted according to the intention-to-treat principle, 
“supplemented by more informative analyses of the sensitivity of results to 
different.”  It is difficult to understand concretely what exactly this means.  
The authors intend to use linear mixed models, as well as exploratory analysis 
of the heterogeneity of treatment effects.  Subgroup analyses will include 
those according to basic demographics and well as all-cause acute care use 
prior to study enrollment. 
13. Results: 
magnitude and 
direction (point 
estimate); 
random 
error/precision 
(confidence 
interval); 
statistical 
significance  
 
Presently, there are no data available for this study!  The point of this paper, 
from the authors’ perspective, was to present and explain the components of 
their quality improvement initiative, including, importantly, how it was 
developed, the rationale for the steps taken in its development, and what steps 
were involved in the implementation process.  The results of the study are to 
be published at a later date. 
14. Clinical/public 
health importance 
of the result 
(explain) for the 
source population 
and wider 
populations  
 
There are not yet published results, but this fact diminishes the public health 
importance of this trial, I feel, only marginally.  From this systematic review’s 
purview, it is clear that very few studies answering this type of question exist.  
In light of this, this paper’s detail of the development of a quality 
improvement initiative and its implementation across several clinical centers 
in a randomized fashion is of extraordinary public health importance.  While 
still clinically relevant, the implications this trial has for clinical practice are 
less clear given the fact that results of the study are not yet available. 
15. Overall 
judgment of 
internal validity 
(good, fair, poor – 
explain)  
 
Fair.  Though there is minimal risk of measurement bias, there is moderate 
risk of selection bias and mild to moderate risk of confounding (in absence of 
Table 1, despite randomization). 
16. External 
validity: 
applicability of 
findings to other 
populations 
beyond the source 
population  
 
For reasons described above, I am concerned about this study’s applicability 
to wider populations beyond the source.  This is one of the main study 
limitations I have identified. 
 
1. Citation (JAMA 
style) 
 
Walls TA, Hughes NT, Mullan PC, Chamberlain JM, Brown K. 
“Improving Pediatric Asthma Outcomes in a Community Emergency 
Department.”  Pediatrics. 2017 Jan; 139(1). pii: e20160088. doi: 
10.1542/peds.2016-0088. Epub 2016 Dec 8. 
2. Study question and 
research design  
 
The significance and background the authors offer highlight the 
importance of this issue and studying ways to change the current state of 
practice.  Specifically, they note that hundreds of thousands of pediatric 
patients with asthma present for care of acute asthma exacerbations in the 
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setting of a community emergency department (ED), i.e. an emergency 
department that is both not associated with an academic medical center 
and one that is not specialized in providing care for children under the age 
of 18.  Studies have shown that, with large numbers of pediatric 
asthmatics presenting for acute care in the face of limited resources and 
provider knowledge in community EDs, a disproportionate number of 
management errors occur compared to management of the presenting 
problem in tertiary care settings.  Not only that, but studies have also 
shown that pediatric patients presenting to community emergency 
departments for acute asthma management experience poorer health 
outcomes, a fact that, especially considering the aforementioned large 
numbers of patients comprising this subgroup, is highly concerning.  The 
authors of this study designed and implemented a quality improvement 
initiative in a community hospital emergency department in an attempt to 
address this issue.  Specifically, the authors of the study, providers at a 
tertiary care emergency medical center, developed a partnership with 
providers at a community emergency medical center that allowed 
implementation of a quality improvement initiative aimed at reducing the 
number of pediatrics patients with asthma who required transfer to a 
tertiary medical center for continued care after their initial presentation.  
The providers from the community emergency center were also 
motivated, in part, by a recent completion of National Pediatric Readiness 
Survey.  Details of this quality improvement initiative’s study design 
included the following: the authors’ collaboration with a multidisciplinary 
team of providers at the community ED; and adaptation of a national 
guidelines supported pediatric asthma pathway aimed at improving care 
of pediatric asthma patients in the community ED setting by introducing 
an asthma score, increasing the proportion of patients receiving steroids, 
decreasing time to steroid administration, and decreasing the number of 
patients who need transfer to a tertiary medical center for additional 
management.  The authors state that they successfully implemented this 
national guideline supported asthma pathway to improve care of pediatric 
asthmatics in their home (tertiary center) institution.  For clarity, it should 
be stated that, because the pathway was supported by national guidelines, 
it was evidence-based.  
3. Source Population 
 
~55,000 patients sought care at the community emergency department 
where the initiative’s implementation would eventually take place.  Of 
these 55,000, approximately 20% were <18 years of age and therefore 
potentially eligible to participate in the study. 
4. Study population 
(descriptive: 
demographics, 
eligibility criteria) and 
how chosen 
(volunteers, 
recruitment, tertiary 
care clinics, 
population-based, etc) 
The process of obtaining the study population from the source can be 
summarized as including the following: 
1) Chart review of all patients age 2 to 17 years who presented to the 
community ED within the timeframe of the study’s start date (see below); 
2) Review of the initial clinical impression documented by the medical 
provider in the electronic health record (EHR); 
3) Inclusion of patients only if the provider documented a clinical 
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 impression of “wheezing,” “asthma,” or “bronchospasm.”  The rationale 
for eligibility criteria based, in large part, on information documented in 
the clinical impression section of the EHR as opposed to that documented 
in the chief complaint section or use of documented International 
Classification of Diseases, Ninth Revision (ICD9) codes was that the 
authors found that the chief complaints were not sensitive enough, and 
that ICD9 codes and discharge diagnoses were not specific, often 
including diagnoses of asthma or wheezing for a patient whose chart 
provided no other evidence of asthma as the chief complaint and no 
documented respiratory physical exam signs that would be consistent with 
this diagnosis. 
 
The authors took part in the chart review of potential study subjects 12 
months before implementation of the asthma pathway, and 19 months 
after its implementation.   
5. Initial comparability 
of groups (ie, 
randomization or 
group composition; 
concealment of 
allocation) 
 
This part of the appraisal guide is not applicable to the quality 
improvement research methodology, as there is no randomization of 
groups and baseline characteristics of members of the study population 
beyond those identified during the inclusion/exclusion process are not 
recorded (a limitation of this type of research, perhaps).   
6. Drop outs (no 
endpoint data), 
adherence, cross-overs 
(other terms: attrition; 
loss to follow-up) 
 
This part of the appraisal guide is not applicable to the quality 
improvement research methodology, as this research is conducted in a 
way that systematically implements small scale improvements on a 
population-level followed by assessment of the effect on population-based 
outcomes. 
7. Potential for 
selection bias (grade + 
to +++, and explain) 
 
+.  For all intents and purposes, selection bias in this type of study is 
negligible, as the processes that often predispose studies to this type of 
bias (i.e. subject recruitment, study arms requiring an allocation 
procedure, randomization, etc.) were not parts of this research.  It is also 
unlikely that, given the discussion about the source and subject population 
and how each were obtained, selection of the group of people to which 
quality improvement interventions were applied actually affected the 
accuracy of results. 
8. Measurement (of 
exposure/intervention; 
outcomes; potential 
confounders): 
reliability and validity 
of measurement 
instruments; how 
measurements were 
performed; include 
blinding if needed) 
 
Here, again, it is helpful to review what the authors of this study did and 
how they did it. 
Intervention implemented: an evidence-based pediatric asthma pathway 
that mirrored one already implemented at the authors’ institution and that 
was designed by ED providers and hospitalist divisions at this institution 
in accordance with best evidence clinical practice.  The investigators 
implemented this quality improvement intervention by providing decision 
support in a way that was familiar and helpful to members of the 
community emergency department staff.  Specifically, the community ED 
already had evidenced-based practice pathways for other common 
diagnoses, such as sepsis, myocardial infarction, and pneumonia, etc. that 
they found useful and were successful in following.  This study’s 
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implementation process capitalized off of this preexisting knowledge by 
using implementation techniques similar to the ones staff members of the 
community ED noted were effective.  Another strategy for 
implementation included use of change concepts for standardization, 
development of operational definitions, and moving steps in a process 
closer together.  They define a change concept as an “approach to change 
found to be useful in developing specific ideas for changes that lead to 
improvement.”  Measurement of key components of the asthma pathway 
implemented can be summarized as including the following: 
1) Documentation of an asthma score: components of the score were 
adapted from several previously validated scores and modified to allow 
easier communication between physicians, nurses, and respiratory 
therapists in the ED.  Scores range from 0 to 10, with a score greater than 
or equal to 4 considered moderate to severe. 
2) Application of the concept of moving steps in a process closer together: 
provided nurse-initiated therapies for patients, including early use of 
bronchodilators and corticosteroids. 
3) Disciplinary partnership between key stakeholders which included: 
nurses, respiratory therapists, pharmacists, physicians, nurse educators, 
and the medical director. 
4) Before implementation, a meeting took place to discuss the best way 
for implementation into the community ED, and to discuss potential 
barriers to implementation: opted to implement pathway into EHR but 
split it into a provider and triage order set in a way that built on and 
mirrored current evidence-based care practices already in place for other 
conditions in the ED, as noted briefly above. 
5) Adjustments to the asthma pathway to facilitate compliance in the 
community ED included the following: increasing the availability of 
respiratory therapists in the ED to administer multiple doses of 
bronchodilators to patients with severe asthma; making additional 
medications available from the pharmacy; moving a medication 
dispensing system to the triage area for earlier initiation of treatment. 
6) Meeting with staff members of the community ED to discuss the 
evidence supporting the asthma pathway. 
7) A nurse from the authors’ home institution met with nurse educators 
from the community ED to train them on assigning an asthma score; these 
nurse educators then trained nursing staff at the community ED on 
assigning an asthma score and on the details of the asthma pathway.  
Nurses also received a quick reference card with the asthma scoring 
system. 
8) Two study investigators presented the asthma pathway to ED providers 
at physician staff meetings to familiarize them with the pathway.  One 
investigator worked with the community ED pharmacist to ensure proper 
dosing and availability of medications in the order sets.  An investigator 
also met with the community ED information technologist to assist in 
incorporating the pathway into the order sets. 
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9) Intervention was implemented in August 2013. 
10) Nurses received continued education on asthma scoring at annual 
skills days. 
11) Community ED staff were surveyed for feedback on pathway 
implementation in March of 2014. 
 12) Survey results and preliminary outcome measures were presented to 
community ED physicians in May of 2014. 
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Process measures included the following: the proportion of children who 
had an asthma score recorded; the proportion of children who received 
steroids; for those children who received steroids, time from triage arrival 
to steroid administration. 
 
Outcome measures included the following: the proportion of children who 
needed transfer to an outside hospital for additional care.  As a balancing 
measure, the proportion of patients with asthma-related visits to the 
community ED within 7 days of the patient’s initial ED visit was 
examined.   
9. Potential for 
measurement bias 
(grade + to +++, 
explain) 
 
+.  Minimal risk of bias given systematic ways of determining exposure, 
intervention and measuring outcomes. 
10. Potential 
confounders (name 
what they are and how 
each was controlled: 
ie, by randomization, 
restriction, statistical 
adjustment, 
stratification, etc) 
This part of the appraisal guide is not applicable to the quality 
improvement research methodology, as this research is conducted in a 
way that systematically implements small scale improvements on a 
population-level followed by assessment of the effect on population-based 
outcomes. 
11. Potential for 
confounding (grade + 
to +++, explain)  
 
Not applicable here, for the same reason as directly above. 
12. Analysis (intention 
to treat if applicable, 
other adjustment) 
 
Primary statistical analyses were based on statistical process control 
methods to demonstrate changes in the designated process and outcome 
measures over time.  Control limits were set at three standard deviations 
from the mean; standard criteria to determine special cause variation 
(change that was due to the intervention) were used.  To analyze return 
visits, the authors compared proportions before and after the intervention 
using the chi-squared test.  Secondary analyses included calculation of 
odds ratios and p values.  A p value < 0.05 was considered significant. 
13. Results: magnitude N= 724 patients (4.4% of the total number of patients aged 2-17 who 
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and direction (point 
estimate); random 
error/precision 
(confidence interval); 
statistical significance  
 
presented to the community ED during the study timeframe); 289 of these 
patients were included during the baseline or pre-intervention 
implementation period; and 435 of these patients were included after the 
intervention was implemented. 
 
64% of patients were assigned an asthma score after pathway 
implementation. 
 
During the baseline period, 60% of patients received corticosteroids 
during their ED visit; after pathway implementation, 76% received 
steroids during their ED visit (OR 2.2; 95% CI, 1.6-3.0; p<0.0001). 
 
After pathway implementation, the mean time to steroid administration 
decreased significantly, from 196 minutes to 105 minutes (p=0.00001). 
 
Significantly fewer patients needed transfer for additional care after the 
pathway was implemented (10% vs. 14%, OR 0.63, CI 0.40-0.99, 
p=0.046). 
 
There were no significant differences in return rates for patients seen 
during the baseline, pre-intervention period and those seen after pathway 
implementation (2.8% vs. 1.1%, p=0.12). 
14. Clinical/public 
health importance of 
the result (explain) for 
the source population 
and wider populations  
 
Large clinical and public health importance, as this study addresses the 
care of pediatric asthmatics using a population-based (quality 
improvement)-based approach, the data on which is limited and sparing.  
The study highlights the details of the successful implementation of a 
quality improvement initiative, importantly; this is the primary question 
this systematic review seeks to answer.  There is a lot of information here, 
and a lot of knowledge can be gleaned from the methods the researchers 
involved in this study used for the purposes of constructing similar study 
designs to answer similar or different questions.  Also of importance, this 
study demonstrates that a quality improvement initiative can be 
implemented with a high level of success, and that a tertiary medical 
center, an institution with a fair amount of resources, can partner with a 
community medical center, an institution with much fewer resources, to 
improve the care of patients using best clinical practices.  
15. Overall judgment 
of internal validity 
(good, fair, poor – 
explain)  
 
Good.  This study demonstrated a low risk of selection and measurement 
bias, and it was easy to understand and follow what the authors set out to 
do, the steps they took to complete each task, and why they thought the 
conclusions they drew were valid and robust. 
16. External validity: 
applicability of 
findings to other 
populations beyond 
the source population  
 
With sound methodology, the results of this study are highly applicable to 
wider populations that even likely includes different clinical settings 
beyond just a tertiary care center and community medical center. 
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